1: GO: Molecular Function [Display Chart]
685 annotations before applied cutoff / 18819 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0008094
|
DNA-dependent ATPase activity
|
|
1.931E-19
|
1.323E-16
|
9.400E-16
|
1.323E-16
|
21
|
93
|
2
|
GO:0003678
|
DNA helicase activity
|
|
3.835E-17
|
1.314E-14
|
9.337E-14
|
2.627E-14
|
17
|
65
|
3
|
GO:0004386
|
helicase activity
|
|
7.610E-16
|
1.306E-13
|
9.283E-13
|
5.213E-13
|
23
|
172
|
4
|
GO:0003697
|
single-stranded DNA binding
|
|
8.621E-16
|
1.306E-13
|
9.283E-13
|
5.905E-13
|
19
|
105
|
5
|
GO:0003684
|
damaged DNA binding
|
|
9.534E-16
|
1.306E-13
|
9.283E-13
|
6.531E-13
|
16
|
65
|
6
|
GO:0043142
|
single-stranded DNA-dependent ATPase activity
|
|
5.229E-12
|
5.969E-10
|
4.243E-9
|
3.582E-9
|
8
|
14
|
7
|
GO:0016887
|
ATPase activity
|
|
1.899E-11
|
1.858E-9
|
1.321E-8
|
1.301E-8
|
29
|
446
|
8
|
GO:0000217
|
DNA secondary structure binding
|
|
4.439E-11
|
3.801E-9
|
2.702E-8
|
3.041E-8
|
9
|
25
|
9
|
GO:0042623
|
ATPase activity, coupled
|
|
4.068E-9
|
3.096E-7
|
2.201E-6
|
2.786E-6
|
22
|
332
|
10
|
GO:0004536
|
deoxyribonuclease activity
|
|
7.831E-9
|
5.284E-7
|
3.756E-6
|
5.364E-6
|
13
|
110
|
11
|
GO:0004518
|
nuclease activity
|
|
8.486E-9
|
5.284E-7
|
3.756E-6
|
5.813E-6
|
18
|
230
|
12
|
GO:0042393
|
histone binding
|
|
1.037E-8
|
5.922E-7
|
4.209E-6
|
7.107E-6
|
16
|
181
|
13
|
GO:0043138
|
3'-5' DNA helicase activity
|
|
1.452E-8
|
7.651E-7
|
5.438E-6
|
9.946E-6
|
6
|
13
|
14
|
GO:0004003
|
ATP-dependent DNA helicase activity
|
|
2.235E-8
|
1.094E-6
|
7.773E-6
|
1.531E-5
|
9
|
47
|
15
|
GO:0004527
|
exonuclease activity
|
|
2.971E-8
|
1.357E-6
|
9.643E-6
|
2.035E-5
|
11
|
82
|
16
|
GO:0000400
|
four-way junction DNA binding
|
|
6.530E-8
|
2.796E-6
|
1.987E-5
|
4.473E-5
|
6
|
16
|
17
|
GO:0004520
|
endodeoxyribonuclease activity
|
|
1.401E-7
|
5.325E-6
|
3.785E-5
|
9.597E-5
|
11
|
95
|
18
|
GO:0016895
|
exodeoxyribonuclease activity, producing 5'-phosphomonoesters
|
|
1.477E-7
|
5.325E-6
|
3.785E-5
|
1.012E-4
|
6
|
18
|
19
|
GO:0004529
|
exodeoxyribonuclease activity
|
|
1.477E-7
|
5.325E-6
|
3.785E-5
|
1.012E-4
|
6
|
18
|
20
|
GO:0034061
|
DNA polymerase activity
|
|
3.605E-7
|
1.235E-5
|
8.775E-5
|
2.469E-4
|
8
|
47
|
21
|
GO:0032405
|
MutLalpha complex binding
|
|
6.540E-7
|
2.133E-5
|
1.516E-4
|
4.480E-4
|
4
|
6
|
22
|
GO:0017056
|
structural constituent of nuclear pore
|
|
2.460E-6
|
7.659E-5
|
5.444E-4
|
1.685E-3
|
5
|
16
|
23
|
GO:0003887
|
DNA-directed DNA polymerase activity
|
|
2.651E-6
|
7.895E-5
|
5.611E-4
|
1.816E-3
|
6
|
28
|
24
|
GO:0032404
|
mismatch repair complex binding
|
|
2.982E-6
|
8.512E-5
|
6.050E-4
|
2.043E-3
|
4
|
8
|
25
|
GO:0033170
|
protein-DNA loading ATPase activity
|
|
5.306E-6
|
1.328E-4
|
9.438E-4
|
3.635E-3
|
4
|
9
|
26
|
GO:0003688
|
DNA replication origin binding
|
|
5.306E-6
|
1.328E-4
|
9.438E-4
|
3.635E-3
|
4
|
9
|
27
|
GO:0003689
|
DNA clamp loader activity
|
|
5.306E-6
|
1.328E-4
|
9.438E-4
|
3.635E-3
|
4
|
9
|
28
|
GO:0008026
|
ATP-dependent helicase activity
|
|
5.757E-6
|
1.328E-4
|
9.438E-4
|
3.943E-3
|
10
|
112
|
29
|
GO:0070035
|
purine NTP-dependent helicase activity
|
|
5.757E-6
|
1.328E-4
|
9.438E-4
|
3.943E-3
|
10
|
112
|
30
|
GO:0016796
|
exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters
|
|
5.816E-6
|
1.328E-4
|
9.438E-4
|
3.984E-3
|
7
|
48
|
31
|
GO:0004519
|
endonuclease activity
|
|
6.562E-6
|
1.450E-4
|
1.031E-3
|
4.495E-3
|
12
|
167
|
32
|
GO:0008408
|
3'-5' exonuclease activity
|
|
1.005E-5
|
2.152E-4
|
1.530E-3
|
6.887E-3
|
7
|
52
|
33
|
GO:0008309
|
double-stranded DNA exodeoxyribonuclease activity
|
|
1.221E-5
|
2.535E-4
|
1.802E-3
|
8.366E-3
|
3
|
4
|
34
|
GO:0030983
|
mismatched DNA binding
|
|
2.014E-5
|
4.057E-4
|
2.883E-3
|
1.379E-2
|
4
|
12
|
35
|
GO:0051539
|
4 iron, 4 sulfur cluster binding
|
|
2.698E-5
|
5.280E-4
|
3.753E-3
|
1.848E-2
|
6
|
41
|
36
|
GO:0070182
|
DNA polymerase binding
|
|
2.875E-5
|
5.471E-4
|
3.888E-3
|
1.969E-2
|
4
|
13
|
37
|
GO:0032135
|
DNA insertion or deletion binding
|
|
5.975E-5
|
1.077E-3
|
7.656E-3
|
4.093E-2
|
3
|
6
|
38
|
GO:0003910
|
DNA ligase (ATP) activity
|
|
5.975E-5
|
1.077E-3
|
7.656E-3
|
4.093E-2
|
3
|
6
|
39
|
GO:0003909
|
DNA ligase activity
|
|
1.034E-4
|
1.817E-3
|
1.291E-2
|
7.085E-2
|
3
|
7
|
40
|
GO:0016779
|
nucleotidyltransferase activity
|
|
1.413E-4
|
2.232E-3
|
1.586E-2
|
9.677E-2
|
9
|
132
|
41
|
GO:0035173
|
histone kinase activity
|
|
1.454E-4
|
2.232E-3
|
1.586E-2
|
9.963E-2
|
4
|
19
|
42
|
GO:0044824
|
retroviral 3' processing activity
|
|
1.466E-4
|
2.232E-3
|
1.586E-2
|
1.004E-1
|
6
|
55
|
43
|
GO:0008907
|
integrase activity
|
|
1.466E-4
|
2.232E-3
|
1.586E-2
|
1.004E-1
|
6
|
55
|
44
|
GO:0044823
|
retroviral integrase activity
|
|
1.466E-4
|
2.232E-3
|
1.586E-2
|
1.004E-1
|
6
|
55
|
45
|
GO:0043765
|
T/G mismatch-specific endonuclease activity
|
|
1.466E-4
|
2.232E-3
|
1.586E-2
|
1.004E-1
|
6
|
55
|
46
|
GO:0036310
|
annealing helicase activity
|
|
1.637E-4
|
2.243E-3
|
1.594E-2
|
1.121E-1
|
3
|
8
|
47
|
GO:0048256
|
flap endonuclease activity
|
|
1.637E-4
|
2.243E-3
|
1.594E-2
|
1.121E-1
|
3
|
8
|
48
|
GO:0003896
|
DNA primase activity
|
|
1.637E-4
|
2.243E-3
|
1.594E-2
|
1.121E-1
|
3
|
8
|
49
|
GO:0000150
|
recombinase activity
|
|
1.637E-4
|
2.243E-3
|
1.594E-2
|
1.121E-1
|
3
|
8
|
50
|
GO:0032552
|
deoxyribonucleotide binding
|
|
1.637E-4
|
2.243E-3
|
1.594E-2
|
1.121E-1
|
3
|
8
|
Show 45 more annotations
|
2: GO: Biological Process [Display Chart]
2504 annotations before applied cutoff / 18785 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0006260
|
DNA replication
|
|
2.401E-72
|
6.011E-69
|
5.051E-68
|
6.011E-69
|
79
|
346
|
2
|
GO:0006261
|
DNA-dependent DNA replication
|
|
1.082E-55
|
1.354E-52
|
1.138E-51
|
2.708E-52
|
49
|
134
|
3
|
GO:0006310
|
DNA recombination
|
|
9.770E-50
|
8.154E-47
|
6.852E-46
|
2.446E-46
|
57
|
268
|
4
|
GO:0071103
|
DNA conformation change
|
|
9.737E-37
|
6.096E-34
|
5.122E-33
|
2.438E-33
|
48
|
285
|
5
|
GO:0000082
|
G1/S transition of mitotic cell cycle
|
|
1.060E-34
|
5.310E-32
|
4.462E-31
|
2.655E-31
|
44
|
248
|
6
|
GO:0006312
|
mitotic recombination
|
|
1.470E-34
|
6.135E-32
|
5.155E-31
|
3.681E-31
|
25
|
45
|
7
|
GO:0000731
|
DNA synthesis involved in DNA repair
|
|
5.474E-34
|
1.958E-31
|
1.645E-30
|
1.371E-30
|
29
|
75
|
8
|
GO:0044843
|
cell cycle G1/S phase transition
|
|
6.305E-34
|
1.973E-31
|
1.658E-30
|
1.579E-30
|
44
|
258
|
9
|
GO:0000722
|
telomere maintenance via recombination
|
|
1.369E-30
|
3.810E-28
|
3.202E-27
|
3.429E-27
|
21
|
34
|
10
|
GO:0006302
|
double-strand break repair
|
|
2.818E-30
|
7.056E-28
|
5.929E-27
|
7.056E-27
|
37
|
196
|
11
|
GO:0006270
|
DNA replication initiation
|
|
3.379E-30
|
7.692E-28
|
6.463E-27
|
8.461E-27
|
21
|
35
|
12
|
GO:0022616
|
DNA strand elongation
|
|
9.329E-30
|
1.947E-27
|
1.636E-26
|
2.336E-26
|
20
|
31
|
13
|
GO:0071897
|
DNA biosynthetic process
|
|
4.696E-29
|
9.045E-27
|
7.600E-26
|
1.176E-25
|
37
|
211
|
14
|
GO:0006271
|
DNA strand elongation involved in DNA replication
|
|
2.919E-28
|
5.221E-26
|
4.387E-25
|
7.309E-25
|
18
|
25
|
15
|
GO:0007067
|
mitotic nuclear division
|
|
2.889E-25
|
4.822E-23
|
4.052E-22
|
7.233E-22
|
46
|
455
|
16
|
GO:0000075
|
cell cycle checkpoint
|
|
4.429E-25
|
6.932E-23
|
5.825E-22
|
1.109E-21
|
35
|
234
|
17
|
GO:0000724
|
double-strand break repair via homologous recombination
|
|
7.447E-25
|
1.097E-22
|
9.217E-22
|
1.865E-21
|
25
|
93
|
18
|
GO:0000725
|
recombinational repair
|
|
1.001E-24
|
1.393E-22
|
1.171E-21
|
2.507E-21
|
25
|
94
|
19
|
GO:0000732
|
strand displacement
|
|
1.597E-23
|
2.104E-21
|
1.768E-20
|
3.998E-20
|
16
|
26
|
20
|
GO:0000723
|
telomere maintenance
|
|
1.389E-22
|
1.739E-20
|
1.462E-19
|
3.479E-19
|
27
|
140
|
21
|
GO:0051052
|
regulation of DNA metabolic process
|
|
3.790E-22
|
4.519E-20
|
3.797E-19
|
9.490E-19
|
39
|
370
|
22
|
GO:0032392
|
DNA geometric change
|
|
4.107E-22
|
4.674E-20
|
3.928E-19
|
1.028E-18
|
22
|
81
|
23
|
GO:0032200
|
telomere organization
|
|
1.644E-21
|
1.790E-19
|
1.504E-18
|
4.116E-18
|
27
|
153
|
24
|
GO:0032508
|
DNA duplex unwinding
|
|
2.467E-21
|
2.574E-19
|
2.163E-18
|
6.178E-18
|
21
|
76
|
25
|
GO:0007059
|
chromosome segregation
|
|
7.990E-21
|
8.003E-19
|
6.725E-18
|
2.001E-17
|
36
|
334
|
26
|
GO:0031570
|
DNA integrity checkpoint
|
|
1.580E-19
|
1.522E-17
|
1.279E-16
|
3.957E-16
|
26
|
164
|
27
|
GO:0072331
|
signal transduction by p53 class mediator
|
|
3.452E-19
|
3.201E-17
|
2.690E-16
|
8.644E-16
|
31
|
263
|
28
|
GO:0006323
|
DNA packaging
|
|
4.257E-19
|
3.589E-17
|
3.015E-16
|
1.066E-15
|
28
|
206
|
29
|
GO:0065004
|
protein-DNA complex assembly
|
|
4.299E-19
|
3.589E-17
|
3.015E-16
|
1.077E-15
|
29
|
225
|
30
|
GO:0000819
|
sister chromatid segregation
|
|
4.299E-19
|
3.589E-17
|
3.015E-16
|
1.077E-15
|
29
|
225
|
31
|
GO:0051321
|
meiotic cell cycle
|
|
2.315E-18
|
1.870E-16
|
1.571E-15
|
5.797E-15
|
29
|
239
|
32
|
GO:0098813
|
nuclear chromosome segregation
|
|
2.958E-18
|
2.314E-16
|
1.945E-15
|
7.406E-15
|
31
|
283
|
33
|
GO:0071824
|
protein-DNA complex subunit organization
|
|
1.113E-17
|
8.449E-16
|
7.100E-15
|
2.788E-14
|
29
|
253
|
34
|
GO:0007062
|
sister chromatid cohesion
|
|
2.229E-16
|
1.642E-14
|
1.379E-13
|
5.581E-13
|
21
|
127
|
35
|
GO:0007093
|
mitotic cell cycle checkpoint
|
|
2.608E-16
|
1.866E-14
|
1.568E-13
|
6.530E-13
|
23
|
162
|
36
|
GO:0000077
|
DNA damage checkpoint
|
|
1.038E-15
|
7.221E-14
|
6.068E-13
|
2.599E-12
|
22
|
154
|
37
|
GO:0000083
|
regulation of transcription involved in G1/S transition of mitotic cell cycle
|
|
1.242E-15
|
8.406E-14
|
7.064E-13
|
3.110E-12
|
12
|
27
|
38
|
GO:0000086
|
G2/M transition of mitotic cell cycle
|
|
2.009E-15
|
1.324E-13
|
1.113E-12
|
5.031E-12
|
24
|
197
|
39
|
GO:0042769
|
DNA damage response, detection of DNA damage
|
|
2.104E-15
|
1.351E-13
|
1.135E-12
|
5.269E-12
|
13
|
36
|
40
|
GO:0045930
|
negative regulation of mitotic cell cycle
|
|
4.520E-15
|
2.830E-13
|
2.378E-12
|
1.132E-11
|
25
|
225
|
41
|
GO:0044839
|
cell cycle G2/M phase transition
|
|
5.573E-15
|
3.404E-13
|
2.860E-12
|
1.396E-11
|
24
|
206
|
42
|
GO:0090305
|
nucleic acid phosphodiester bond hydrolysis
|
|
5.849E-15
|
3.444E-13
|
2.894E-12
|
1.465E-11
|
27
|
272
|
43
|
GO:1901796
|
regulation of signal transduction by p53 class mediator
|
|
5.914E-15
|
3.444E-13
|
2.894E-12
|
1.481E-11
|
22
|
167
|
44
|
GO:0006297
|
nucleotide-excision repair, DNA gap filling
|
|
1.288E-14
|
7.332E-13
|
6.161E-12
|
3.226E-11
|
11
|
24
|
45
|
GO:0006301
|
postreplication repair
|
|
3.331E-14
|
1.854E-12
|
1.558E-11
|
8.342E-11
|
14
|
54
|
46
|
GO:0044786
|
cell cycle DNA replication
|
|
3.573E-14
|
1.945E-12
|
1.635E-11
|
8.948E-11
|
12
|
34
|
47
|
GO:0006284
|
base-excision repair
|
|
4.254E-14
|
2.267E-12
|
1.905E-11
|
1.065E-10
|
13
|
44
|
48
|
GO:0006298
|
mismatch repair
|
|
5.367E-14
|
2.800E-12
|
2.353E-11
|
1.344E-10
|
12
|
35
|
49
|
GO:1903046
|
meiotic cell cycle process
|
|
1.707E-13
|
8.562E-12
|
7.194E-11
|
4.275E-10
|
22
|
196
|
50
|
GO:0010948
|
negative regulation of cell cycle process
|
|
1.710E-13
|
8.562E-12
|
7.194E-11
|
4.281E-10
|
24
|
240
|
Show 45 more annotations
|
3: GO: Cellular Component [Display Chart]
289 annotations before applied cutoff / 19172 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0098687
|
chromosomal region
|
|
2.922E-34
|
4.257E-32
|
2.659E-31
|
8.444E-32
|
49
|
345
|
2
|
GO:0005657
|
replication fork
|
|
2.946E-34
|
4.257E-32
|
2.659E-31
|
8.515E-32
|
28
|
67
|
3
|
GO:0000793
|
condensed chromosome
|
|
8.270E-25
|
7.967E-23
|
4.976E-22
|
2.390E-22
|
33
|
208
|
4
|
GO:0043596
|
nuclear replication fork
|
|
8.168E-18
|
5.901E-16
|
3.686E-15
|
2.361E-15
|
15
|
41
|
5
|
GO:0000781
|
chromosome, telomeric region
|
|
1.537E-17
|
8.881E-16
|
5.547E-15
|
4.441E-15
|
24
|
163
|
6
|
GO:0000775
|
chromosome, centromeric region
|
|
2.622E-17
|
1.263E-15
|
7.886E-15
|
7.576E-15
|
25
|
185
|
7
|
GO:0000784
|
nuclear chromosome, telomeric region
|
|
4.639E-16
|
1.915E-14
|
1.196E-13
|
1.341E-13
|
21
|
134
|
8
|
GO:0000785
|
chromatin
|
|
1.017E-15
|
3.674E-14
|
2.295E-13
|
2.939E-13
|
36
|
489
|
9
|
GO:0042555
|
MCM complex
|
|
1.336E-15
|
4.289E-14
|
2.679E-13
|
3.860E-13
|
9
|
11
|
10
|
GO:0030894
|
replisome
|
|
7.528E-15
|
2.175E-13
|
1.359E-12
|
2.175E-12
|
12
|
31
|
11
|
GO:0032993
|
protein-DNA complex
|
|
2.499E-11
|
6.565E-10
|
4.100E-9
|
7.221E-9
|
19
|
184
|
12
|
GO:0000779
|
condensed chromosome, centromeric region
|
|
3.129E-11
|
7.380E-10
|
4.609E-9
|
9.043E-9
|
15
|
105
|
13
|
GO:0000776
|
kinetochore
|
|
3.320E-11
|
7.380E-10
|
4.609E-9
|
9.594E-9
|
16
|
124
|
14
|
GO:0000777
|
condensed chromosome kinetochore
|
|
9.379E-11
|
1.936E-9
|
1.209E-8
|
2.710E-8
|
14
|
95
|
15
|
GO:0043601
|
nuclear replisome
|
|
1.352E-10
|
2.604E-9
|
1.626E-8
|
3.906E-8
|
9
|
28
|
16
|
GO:0000794
|
condensed nuclear chromosome
|
|
1.490E-9
|
2.692E-8
|
1.681E-7
|
4.307E-7
|
13
|
97
|
17
|
GO:0005663
|
DNA replication factor C complex
|
|
3.668E-9
|
6.235E-8
|
3.894E-7
|
1.060E-6
|
5
|
6
|
18
|
GO:0000790
|
nuclear chromatin
|
|
1.342E-8
|
2.155E-7
|
1.346E-6
|
3.879E-6
|
21
|
326
|
19
|
GO:0031261
|
DNA replication preinitiation complex
|
|
4.327E-8
|
6.582E-7
|
4.111E-6
|
1.251E-5
|
4
|
4
|
20
|
GO:0000792
|
heterochromatin
|
|
5.827E-8
|
8.421E-7
|
5.259E-6
|
1.684E-5
|
11
|
88
|
21
|
GO:0005819
|
spindle
|
|
1.325E-7
|
1.788E-6
|
1.116E-5
|
3.830E-5
|
19
|
308
|
22
|
GO:0005720
|
nuclear heterochromatin
|
|
1.361E-7
|
1.788E-6
|
1.116E-5
|
3.933E-5
|
8
|
42
|
23
|
GO:0016605
|
PML body
|
|
2.211E-7
|
2.779E-6
|
1.735E-5
|
6.391E-5
|
11
|
100
|
24
|
GO:0044450
|
microtubule organizing center part
|
|
2.528E-7
|
3.044E-6
|
1.901E-5
|
7.306E-5
|
13
|
148
|
25
|
GO:0000803
|
sex chromosome
|
|
3.085E-7
|
3.566E-6
|
2.227E-5
|
8.915E-5
|
7
|
32
|
26
|
GO:0005814
|
centriole
|
|
3.649E-7
|
4.056E-6
|
2.533E-5
|
1.055E-4
|
11
|
105
|
27
|
GO:0035861
|
site of double-strand break
|
|
3.867E-7
|
4.139E-6
|
2.585E-5
|
1.118E-4
|
7
|
33
|
28
|
GO:0031298
|
replication fork protection complex
|
|
6.344E-7
|
6.548E-6
|
4.089E-5
|
1.833E-4
|
4
|
6
|
29
|
GO:0005635
|
nuclear envelope
|
|
8.700E-7
|
8.670E-6
|
5.414E-5
|
2.514E-4
|
22
|
454
|
30
|
GO:0031390
|
Ctf18 RFC-like complex
|
|
1.463E-6
|
1.410E-5
|
8.804E-5
|
4.229E-4
|
4
|
7
|
31
|
GO:0070652
|
HAUS complex
|
|
2.893E-6
|
2.697E-5
|
1.684E-4
|
8.361E-4
|
4
|
8
|
32
|
GO:0000811
|
GINS complex
|
|
3.016E-6
|
2.724E-5
|
1.701E-4
|
8.718E-4
|
3
|
3
|
33
|
GO:0000922
|
spindle pole
|
|
3.864E-6
|
3.384E-5
|
2.113E-4
|
1.117E-3
|
11
|
133
|
34
|
GO:0005658
|
alpha DNA polymerase:primase complex
|
|
1.194E-5
|
1.015E-4
|
6.336E-4
|
3.450E-3
|
3
|
4
|
35
|
GO:0098536
|
deuterosome
|
|
2.952E-5
|
2.396E-4
|
1.497E-3
|
8.531E-3
|
3
|
5
|
36
|
GO:0034399
|
nuclear periphery
|
|
2.985E-5
|
2.396E-4
|
1.497E-3
|
8.627E-3
|
10
|
136
|
37
|
GO:0042575
|
DNA polymerase complex
|
|
3.862E-5
|
3.017E-4
|
1.884E-3
|
1.116E-2
|
4
|
14
|
38
|
GO:0043240
|
Fanconi anaemia nuclear complex
|
|
5.206E-5
|
3.960E-4
|
2.473E-3
|
1.505E-2
|
4
|
15
|
39
|
GO:0000796
|
condensin complex
|
|
5.840E-5
|
4.328E-4
|
2.703E-3
|
1.688E-2
|
3
|
6
|
40
|
GO:0001741
|
XY body
|
|
8.873E-5
|
6.410E-4
|
4.004E-3
|
2.564E-2
|
4
|
17
|
41
|
GO:0005721
|
pericentric heterochromatin
|
|
1.412E-4
|
9.955E-4
|
6.217E-3
|
4.082E-2
|
4
|
19
|
42
|
GO:0000930
|
gamma-tubulin complex
|
|
1.745E-4
|
1.201E-3
|
7.500E-3
|
5.044E-2
|
4
|
20
|
43
|
GO:0032301
|
MutSalpha complex
|
|
2.095E-4
|
1.346E-3
|
8.403E-3
|
6.055E-2
|
2
|
2
|
44
|
GO:0031436
|
BRCA1-BARD1 complex
|
|
2.095E-4
|
1.346E-3
|
8.403E-3
|
6.055E-2
|
2
|
2
|
45
|
GO:1990077
|
primosome complex
|
|
2.095E-4
|
1.346E-3
|
8.403E-3
|
6.055E-2
|
2
|
2
|
46
|
GO:0000808
|
origin recognition complex
|
|
2.375E-4
|
1.460E-3
|
9.120E-3
|
6.863E-2
|
3
|
9
|
47
|
GO:0005664
|
nuclear origin of replication recognition complex
|
|
2.375E-4
|
1.460E-3
|
9.120E-3
|
6.863E-2
|
3
|
9
|
48
|
GO:0061695
|
transferase complex, transferring phosphorus-containing groups
|
|
2.543E-4
|
1.531E-3
|
9.563E-3
|
7.349E-2
|
12
|
245
|
49
|
GO:0031965
|
nuclear membrane
|
|
3.356E-4
|
1.979E-3
|
1.236E-2
|
9.697E-2
|
13
|
290
|
50
|
GO:1990391
|
DNA repair complex
|
|
5.213E-4
|
3.013E-3
|
1.882E-2
|
1.507E-1
|
5
|
46
|
Show 45 more annotations
|
4: Human Phenotype [Display Chart]
685 annotations before applied cutoff / 4410 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
HP:0002575
|
Tracheoesophageal fistula
|
|
3.270E-9
|
1.424E-6
|
1.012E-5
|
2.240E-6
|
8
|
27
|
2
|
HP:0003221
|
Chromosomal breakage induced by crosslinking agents
|
|
4.266E-9
|
1.424E-6
|
1.012E-5
|
2.922E-6
|
6
|
11
|
3
|
HP:0001511
|
Intrauterine growth retardation
|
|
8.282E-9
|
1.424E-6
|
1.012E-5
|
5.673E-6
|
16
|
185
|
4
|
HP:0001909
|
Leukemia
|
|
8.317E-9
|
1.424E-6
|
1.012E-5
|
5.697E-6
|
8
|
30
|
5
|
HP:0002032
|
Esophageal atresia
|
|
1.108E-8
|
1.517E-6
|
1.079E-5
|
7.587E-6
|
8
|
31
|
6
|
HP:0009778
|
Short thumb {has synonym type="layperson"}
|
|
1.190E-7
|
1.230E-5
|
8.741E-5
|
8.150E-5
|
8
|
41
|
7
|
HP:0000957
|
Cafe-au-lait spot
|
|
1.257E-7
|
1.230E-5
|
8.741E-5
|
8.609E-5
|
9
|
57
|
8
|
HP:0003002
|
Breast carcinoma
|
|
1.452E-7
|
1.244E-5
|
8.838E-5
|
9.948E-5
|
8
|
42
|
9
|
HP:0000086
|
Ectopic kidney
|
|
8.077E-7
|
6.147E-5
|
4.369E-4
|
5.533E-4
|
6
|
23
|
10
|
HP:0009777
|
Absent thumb {has synonym type="layperson"}
|
|
1.064E-6
|
7.289E-5
|
5.181E-4
|
7.289E-4
|
6
|
24
|
11
|
HP:0003213
|
Deficient excision of UV-induced pyrimidine dimers in DNA
|
|
3.256E-6
|
1.716E-4
|
1.219E-3
|
2.230E-3
|
4
|
8
|
12
|
HP:0003214
|
Prolonged G2 phase of cell cycle
|
|
3.256E-6
|
1.716E-4
|
1.219E-3
|
2.230E-3
|
4
|
8
|
13
|
HP:0001017
|
Anemic pallor
|
|
3.256E-6
|
1.716E-4
|
1.219E-3
|
2.230E-3
|
4
|
8
|
14
|
HP:0009943
|
Complete duplication of thumb phalanx
|
|
5.794E-6
|
2.646E-4
|
1.880E-3
|
3.969E-3
|
4
|
9
|
15
|
HP:0003220
|
Abnormality of chromosome stability
|
|
5.794E-6
|
2.646E-4
|
1.880E-3
|
3.969E-3
|
4
|
9
|
16
|
HP:0000568
|
Microphthalmia
|
|
8.204E-6
|
3.512E-4
|
2.496E-3
|
5.620E-3
|
11
|
144
|
17
|
HP:0001876
|
Pancytopenia
|
|
9.272E-6
|
3.736E-4
|
2.655E-3
|
6.351E-3
|
7
|
51
|
18
|
HP:0003974
|
Absent radius
|
|
2.923E-5
|
1.112E-3
|
7.906E-3
|
2.002E-2
|
5
|
25
|
19
|
HP:0000081
|
Duplicated collecting system
|
|
3.140E-5
|
1.132E-3
|
8.046E-3
|
2.151E-2
|
4
|
13
|
20
|
HP:0001896
|
Reticulocytopenia
|
|
5.859E-5
|
2.007E-3
|
1.426E-2
|
4.013E-2
|
4
|
15
|
21
|
HP:0001873
|
Thrombocytopenia
|
|
7.195E-5
|
2.347E-3
|
1.668E-2
|
4.928E-2
|
10
|
150
|
22
|
HP:0000085
|
Horseshoe kidney {has synonym type="layperson"}
|
|
8.712E-5
|
2.712E-3
|
1.928E-2
|
5.967E-2
|
5
|
31
|
23
|
HP:0001518
|
Small for gestational age {has synonym type="layperson"}
|
|
1.062E-4
|
3.163E-3
|
2.248E-2
|
7.275E-2
|
8
|
99
|
24
|
HP:0003561
|
Birth length less than 3rd percentile
|
|
1.778E-4
|
5.075E-3
|
3.607E-2
|
1.218E-1
|
3
|
8
|
25
|
HP:0001627
|
Abnormal heart morphology
|
|
2.083E-4
|
5.707E-3
|
4.056E-2
|
1.427E-1
|
5
|
37
|
26
|
HP:0001000
|
Abnormality of skin pigmentation {has synonym type="layperson"}
|
|
4.114E-4
|
1.084E-2
|
7.704E-2
|
2.818E-1
|
4
|
24
|
27
|
HP:0000340
|
Sloping forehead {has synonym type="layperson"}
|
|
4.780E-4
|
1.201E-2
|
8.536E-2
|
3.274E-1
|
5
|
44
|
28
|
HP:0000028
|
Cryptorchidism
|
|
4.909E-4
|
1.201E-2
|
8.536E-2
|
3.363E-1
|
13
|
302
|
29
|
HP:0000104
|
Renal agenesis
|
|
5.894E-4
|
1.392E-2
|
9.895E-2
|
4.037E-1
|
5
|
46
|
30
|
HP:0003100
|
Slender long bone {has synonym type="layperson"}
|
|
6.566E-4
|
1.499E-2
|
1.066E-1
|
4.498E-1
|
4
|
27
|
31
|
HP:0001889
|
Megaloblastic anemia
|
|
8.599E-4
|
1.859E-2
|
1.321E-1
|
5.890E-1
|
3
|
13
|
32
|
HP:0005528
|
Bone marrow hypocellularity
|
|
8.685E-4
|
1.859E-2
|
1.321E-1
|
5.949E-1
|
4
|
29
|
33
|
HP:0011451
|
Congenital microcephaly
|
|
1.338E-3
|
2.695E-2
|
1.916E-1
|
9.164E-1
|
2
|
4
|
34
|
HP:0006628
|
Absent sternal ossification
|
|
1.338E-3
|
2.695E-2
|
1.916E-1
|
9.164E-1
|
2
|
4
|
35
|
HP:0100843
|
Glioblastoma
|
|
1.630E-3
|
3.101E-2
|
2.204E-1
|
1.000E0
|
3
|
16
|
36
|
HP:0002885
|
Medulloblastoma
|
|
1.630E-3
|
3.101E-2
|
2.204E-1
|
1.000E0
|
3
|
16
|
37
|
HP:0008665
|
Clitoral hypertrophy
|
|
1.788E-3
|
3.310E-2
|
2.353E-1
|
1.000E0
|
4
|
35
|
38
|
HP:0002665
|
Lymphoma
|
|
1.989E-3
|
3.585E-2
|
2.548E-1
|
1.000E0
|
4
|
36
|
39
|
HP:0001903
|
Anemia
|
|
2.291E-3
|
4.024E-2
|
2.860E-1
|
1.000E0
|
7
|
122
|
Show 34 more annotations
|
5: Mouse Phenotype [Display Chart]
2118 annotations before applied cutoff / 9299 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
MP:0008866
|
chromosomal instability
|
|
2.597E-27
|
4.903E-24
|
4.038E-23
|
5.501E-24
|
30
|
113
|
2
|
MP:0010094
|
abnormal chromosome stability
|
|
4.630E-27
|
4.903E-24
|
4.038E-23
|
9.807E-24
|
30
|
115
|
3
|
MP:0003077
|
abnormal cell cycle
|
|
1.050E-18
|
7.414E-16
|
6.106E-15
|
2.224E-15
|
35
|
309
|
4
|
MP:0004028
|
chromosome breakage
|
|
1.172E-17
|
6.207E-15
|
5.112E-14
|
2.483E-14
|
19
|
71
|
5
|
MP:0003111
|
abnormal cell nucleus morphology
|
|
7.869E-17
|
3.333E-14
|
2.745E-13
|
1.667E-13
|
26
|
177
|
6
|
MP:0004046
|
abnormal mitosis
|
|
1.120E-14
|
3.953E-12
|
3.256E-11
|
2.372E-11
|
22
|
145
|
7
|
MP:0012431
|
increased lymphoma incidence
|
|
2.674E-14
|
8.092E-12
|
6.664E-11
|
5.664E-11
|
27
|
244
|
8
|
MP:0010296
|
increased hemolymphoid system tumor incidence
|
|
5.014E-14
|
1.327E-11
|
1.093E-10
|
1.062E-10
|
29
|
293
|
9
|
MP:0008058
|
abnormal DNA repair
|
|
1.384E-11
|
3.122E-9
|
2.571E-8
|
2.932E-8
|
17
|
112
|
10
|
MP:0011096
|
embryonic lethality between implantation and somite formation, complete penetrance
|
|
1.474E-11
|
3.122E-9
|
2.571E-8
|
3.122E-8
|
25
|
270
|
11
|
MP:0009850
|
embryonic lethality between implantation and placentation
|
|
4.999E-11
|
9.625E-9
|
7.927E-8
|
1.059E-7
|
31
|
439
|
12
|
MP:0006205
|
embryonic lethality between implantation and somite formation
|
|
1.357E-10
|
2.395E-8
|
1.972E-7
|
2.874E-7
|
25
|
299
|
13
|
MP:0006204
|
embryonic lethality before implantation
|
|
1.806E-10
|
2.943E-8
|
2.424E-7
|
3.826E-7
|
19
|
169
|
14
|
MP:0004966
|
abnormal inner cell mass proliferation
|
|
1.958E-10
|
2.961E-8
|
2.439E-7
|
4.146E-7
|
13
|
68
|
15
|
MP:0004023
|
abnormal chromosome number
|
|
2.226E-10
|
3.144E-8
|
2.589E-7
|
4.716E-7
|
14
|
83
|
16
|
MP:0008943
|
increased sensitivity to induced cell death
|
|
3.000E-10
|
3.971E-8
|
3.271E-7
|
6.354E-7
|
19
|
174
|
17
|
MP:0011094
|
embryonic lethality before implantation, complete penetrance
|
|
8.081E-10
|
1.007E-7
|
8.291E-7
|
1.711E-6
|
17
|
144
|
18
|
MP:0009308
|
increased adenocarcinoma incidence
|
|
2.193E-9
|
2.580E-7
|
2.125E-6
|
4.645E-6
|
18
|
174
|
19
|
MP:0008942
|
abnormal induced cell death
|
|
3.697E-9
|
4.121E-7
|
3.394E-6
|
7.831E-6
|
21
|
248
|
20
|
MP:0004030
|
induced chromosome breakage
|
|
5.790E-9
|
6.131E-7
|
5.049E-6
|
1.226E-5
|
8
|
24
|
21
|
MP:0003702
|
abnormal chromosome morphology
|
|
7.256E-9
|
7.318E-7
|
6.027E-6
|
1.537E-5
|
12
|
74
|
22
|
MP:0013503
|
abnormal embryonic tissue cell apoptosis
|
|
1.153E-8
|
1.110E-6
|
9.144E-6
|
2.443E-5
|
17
|
171
|
23
|
MP:0004024
|
aneuploidy
|
|
1.402E-8
|
1.291E-6
|
1.063E-5
|
2.970E-5
|
11
|
63
|
24
|
MP:0004227
|
increased cellular sensitivity to ionizing radiation
|
|
2.095E-8
|
1.849E-6
|
1.523E-5
|
4.437E-5
|
12
|
81
|
25
|
MP:0008932
|
abnormal embryonic tissue physiology
|
|
2.184E-8
|
1.850E-6
|
1.524E-5
|
4.626E-5
|
22
|
300
|
26
|
MP:0002718
|
abnormal inner cell mass morphology
|
|
3.193E-8
|
2.601E-6
|
2.142E-5
|
6.762E-5
|
12
|
84
|
27
|
MP:0002038
|
increased carcinoma incidence
|
|
4.182E-8
|
3.281E-6
|
2.702E-5
|
8.857E-5
|
22
|
311
|
28
|
MP:0011702
|
abnormal fibroblast proliferation
|
|
5.379E-8
|
4.069E-6
|
3.351E-5
|
1.139E-4
|
16
|
167
|
29
|
MP:0012114
|
absent inner cell mass proliferation
|
|
5.800E-8
|
4.095E-6
|
3.372E-5
|
1.228E-4
|
9
|
43
|
30
|
MP:0010948
|
abnormal double-strand DNA break repair
|
|
5.800E-8
|
4.095E-6
|
3.372E-5
|
1.228E-4
|
9
|
43
|
31
|
MP:0011704
|
decreased fibroblast proliferation
|
|
6.524E-8
|
4.457E-6
|
3.671E-5
|
1.382E-4
|
14
|
127
|
32
|
MP:0002018
|
increased malignant tumor incidence
|
|
9.295E-8
|
6.152E-6
|
5.067E-5
|
1.969E-4
|
24
|
382
|
33
|
MP:0013504
|
increased embryonic tissue cell apoptosis
|
|
2.442E-7
|
1.567E-5
|
1.291E-4
|
5.172E-4
|
14
|
141
|
34
|
MP:0001730
|
embryonic growth arrest
|
|
5.536E-7
|
3.448E-5
|
2.840E-4
|
1.172E-3
|
20
|
303
|
35
|
MP:0010288
|
increased gland tumor incidence
|
|
7.136E-7
|
4.318E-5
|
3.556E-4
|
1.511E-3
|
19
|
280
|
36
|
MP:0004029
|
spontaneous chromosome breakage
|
|
8.278E-7
|
4.870E-5
|
4.011E-4
|
1.753E-3
|
7
|
30
|
37
|
MP:0004957
|
abnormal blastocyst morphology
|
|
1.031E-6
|
5.748E-5
|
4.734E-4
|
2.184E-3
|
16
|
207
|
38
|
MP:0014137
|
abnormal preimplantation embryo morphology
|
|
1.031E-6
|
5.748E-5
|
4.734E-4
|
2.184E-3
|
16
|
207
|
39
|
MP:0005169
|
abnormal male meiosis
|
|
1.443E-6
|
7.834E-5
|
6.452E-4
|
3.055E-3
|
14
|
163
|
40
|
MP:0001930
|
abnormal meiosis
|
|
2.271E-6
|
1.203E-4
|
9.905E-4
|
4.811E-3
|
15
|
194
|
41
|
MP:0008057
|
abnormal DNA replication
|
|
3.383E-6
|
1.748E-4
|
1.439E-3
|
7.165E-3
|
6
|
24
|
42
|
MP:0010293
|
increased integument system tumor incidence
|
|
1.096E-5
|
5.526E-4
|
4.551E-3
|
2.321E-2
|
13
|
168
|
43
|
MP:0010299
|
increased mammary gland tumor incidence
|
|
1.274E-5
|
6.276E-4
|
5.169E-3
|
2.699E-2
|
10
|
100
|
44
|
MP:0010365
|
increased thymus tumor incidence
|
|
1.657E-5
|
7.845E-4
|
6.461E-3
|
3.510E-2
|
10
|
103
|
45
|
MP:0004045
|
abnormal cell cycle checkpoint function
|
|
1.668E-5
|
7.845E-4
|
6.461E-3
|
3.533E-2
|
8
|
63
|
46
|
MP:0002777
|
absent ovarian follicles
|
|
1.704E-5
|
7.845E-4
|
6.461E-3
|
3.609E-2
|
7
|
46
|
47
|
MP:0004815
|
abnormal somatic hypermutation frequency
|
|
1.768E-5
|
7.966E-4
|
6.561E-3
|
3.744E-2
|
5
|
19
|
48
|
MP:0009797
|
abnormal mismatch repair
|
|
2.030E-5
|
8.959E-4
|
7.378E-3
|
4.300E-2
|
4
|
10
|
49
|
MP:0003992
|
increased mortality induced by ionizing radiation
|
|
2.273E-5
|
9.827E-4
|
8.093E-3
|
4.815E-2
|
7
|
48
|
50
|
MP:0001147
|
small testis
|
|
2.345E-5
|
9.935E-4
|
8.182E-3
|
4.968E-2
|
23
|
488
|
Show 45 more annotations
|
6: Domain [Display Chart]
1414 annotations before applied cutoff / 18735 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
PS50051
|
MCM 2
|
PROSITE
|
1.048E-12
|
3.704E-10
|
2.901E-9
|
1.481E-9
|
7
|
8
|
2
|
IPR033762
|
MCM OB
|
InterPro
|
1.048E-12
|
3.704E-10
|
2.901E-9
|
1.481E-9
|
7
|
8
|
3
|
PF17207
|
MCM OB
|
Pfam
|
1.048E-12
|
3.704E-10
|
2.901E-9
|
1.481E-9
|
7
|
8
|
4
|
PS00847
|
MCM 1
|
PROSITE
|
1.048E-12
|
3.704E-10
|
2.901E-9
|
1.481E-9
|
7
|
8
|
5
|
SM00350
|
MCM
|
SMART
|
4.656E-12
|
8.229E-10
|
6.445E-9
|
6.584E-9
|
7
|
9
|
6
|
PF00493
|
MCM
|
Pfam
|
4.656E-12
|
8.229E-10
|
6.445E-9
|
6.584E-9
|
7
|
9
|
7
|
IPR001208
|
MCM dom
|
InterPro
|
4.656E-12
|
8.229E-10
|
6.445E-9
|
6.584E-9
|
7
|
9
|
8
|
IPR031327
|
MCM
|
InterPro
|
4.656E-12
|
8.229E-10
|
6.445E-9
|
6.584E-9
|
7
|
9
|
9
|
IPR018525
|
MCM CS
|
InterPro
|
9.268E-12
|
1.191E-9
|
9.331E-9
|
1.311E-8
|
6
|
6
|
10
|
IPR027925
|
MCM N
|
InterPro
|
9.268E-12
|
1.191E-9
|
9.331E-9
|
1.311E-8
|
6
|
6
|
11
|
PF14551
|
MCM N
|
Pfam
|
9.268E-12
|
1.191E-9
|
9.331E-9
|
1.311E-8
|
6
|
6
|
12
|
SM00382
|
AAA
|
SMART
|
3.231E-9
|
3.372E-7
|
2.641E-6
|
4.568E-6
|
15
|
144
|
13
|
IPR003593
|
AAA+ ATPase
|
InterPro
|
3.231E-9
|
3.372E-7
|
2.641E-6
|
4.568E-6
|
15
|
144
|
14
|
IPR012340
|
NA-bd OB-fold
|
InterPro
|
3.339E-9
|
3.372E-7
|
2.641E-6
|
4.721E-6
|
12
|
84
|
15
|
PF00004
|
AAA
|
Pfam
|
5.700E-8
|
5.373E-6
|
4.208E-5
|
8.059E-5
|
9
|
52
|
16
|
IPR003959
|
ATPase AAA core
|
InterPro
|
8.031E-8
|
7.097E-6
|
5.558E-5
|
1.136E-4
|
9
|
54
|
17
|
IPR008921
|
DNA pol3 clamp-load cplx C
|
InterPro
|
6.561E-7
|
5.458E-5
|
4.274E-4
|
9.278E-4
|
4
|
6
|
18
|
IPR021151
|
GINS complex
|
InterPro
|
3.095E-6
|
2.084E-4
|
1.632E-3
|
4.376E-3
|
3
|
3
|
19
|
IPR013748
|
Rep factorC C
|
InterPro
|
3.095E-6
|
2.084E-4
|
1.632E-3
|
4.376E-3
|
3
|
3
|
20
|
PF05916
|
Sld5
|
Pfam
|
3.095E-6
|
2.084E-4
|
1.632E-3
|
4.376E-3
|
3
|
3
|
21
|
PF08542
|
Rep fac C
|
Pfam
|
3.095E-6
|
2.084E-4
|
1.632E-3
|
4.376E-3
|
3
|
3
|
22
|
PF00533
|
BRCT
|
Pfam
|
6.342E-6
|
4.076E-4
|
3.192E-3
|
8.967E-3
|
5
|
19
|
23
|
IPR004039
|
Rubredoxin-type fold
|
InterPro
|
1.224E-5
|
7.214E-4
|
5.649E-3
|
1.731E-2
|
3
|
4
|
24
|
2.20.28.10
|
-
|
Gene3D
|
1.224E-5
|
7.214E-4
|
5.649E-3
|
1.731E-2
|
3
|
4
|
25
|
SM00292
|
BRCT
|
SMART
|
1.386E-5
|
7.837E-4
|
6.137E-3
|
1.959E-2
|
5
|
22
|
26
|
3.40.50.10190
|
-
|
Gene3D
|
1.749E-5
|
9.514E-4
|
7.451E-3
|
2.474E-2
|
5
|
23
|
27
|
PS50172
|
BRCT
|
PROSITE
|
3.299E-5
|
1.728E-3
|
1.353E-2
|
4.665E-2
|
5
|
26
|
28
|
IPR001357
|
BRCT dom
|
InterPro
|
4.813E-5
|
2.430E-3
|
1.903E-2
|
6.805E-2
|
5
|
28
|
29
|
PF08423
|
Rad51
|
Pfam
|
1.037E-4
|
4.312E-3
|
3.377E-2
|
1.466E-1
|
3
|
7
|
30
|
PS50162
|
RECA 2
|
PROSITE
|
1.037E-4
|
4.312E-3
|
3.377E-2
|
1.466E-1
|
3
|
7
|
31
|
IPR013632
|
DNA recomb/repair Rad51 C
|
InterPro
|
1.037E-4
|
4.312E-3
|
3.377E-2
|
1.466E-1
|
3
|
7
|
32
|
PF06839
|
zf-GRF
|
Pfam
|
1.037E-4
|
4.312E-3
|
3.377E-2
|
1.466E-1
|
3
|
7
|
33
|
IPR020588
|
RecA ATP-bd
|
InterPro
|
1.037E-4
|
4.312E-3
|
3.377E-2
|
1.466E-1
|
3
|
7
|
34
|
IPR010666
|
Znf GRF
|
InterPro
|
1.037E-4
|
4.312E-3
|
3.377E-2
|
1.466E-1
|
3
|
7
|
35
|
IPR018866
|
Znf-4CXXC R1
|
InterPro
|
2.131E-4
|
7.727E-3
|
6.052E-2
|
3.014E-1
|
2
|
2
|
36
|
IPR015163
|
Cdc6 C
|
InterPro
|
2.131E-4
|
7.727E-3
|
6.052E-2
|
3.014E-1
|
2
|
2
|
37
|
PF09079
|
Cdc6 C
|
Pfam
|
2.131E-4
|
7.727E-3
|
6.052E-2
|
3.014E-1
|
2
|
2
|
38
|
SM01074
|
Cdc6 C
|
SMART
|
2.131E-4
|
7.727E-3
|
6.052E-2
|
3.014E-1
|
2
|
2
|
39
|
PF10497
|
zf-4CXXC R1
|
Pfam
|
2.131E-4
|
7.727E-3
|
6.052E-2
|
3.014E-1
|
2
|
2
|
40
|
1.10.10.10
|
-
|
Gene3D
|
3.812E-4
|
1.348E-2
|
1.055E-1
|
5.391E-1
|
11
|
218
|
41
|
PF02319
|
E2F TDP
|
Pfam
|
4.680E-4
|
1.539E-2
|
1.205E-1
|
6.618E-1
|
3
|
11
|
42
|
IPR003316
|
E2F WHTH DNA-bd dom
|
InterPro
|
4.680E-4
|
1.539E-2
|
1.205E-1
|
6.618E-1
|
3
|
11
|
43
|
SM01372
|
E2F TDP
|
SMART
|
4.680E-4
|
1.539E-2
|
1.205E-1
|
6.618E-1
|
3
|
11
|
44
|
3.30.420.10
|
-
|
Gene3D
|
5.989E-4
|
1.571E-2
|
1.230E-1
|
8.469E-1
|
5
|
47
|
45
|
IPR004365
|
NA-bd OB tRNA
|
InterPro
|
6.173E-4
|
1.571E-2
|
1.230E-1
|
8.728E-1
|
3
|
12
|
46
|
PF01336
|
tRNA anti-codon
|
Pfam
|
6.173E-4
|
1.571E-2
|
1.230E-1
|
8.728E-1
|
3
|
12
|
47
|
PF01624
|
MutS I
|
Pfam
|
6.332E-4
|
1.571E-2
|
1.230E-1
|
8.953E-1
|
2
|
3
|
48
|
PF04042
|
DNA pol E B
|
Pfam
|
6.332E-4
|
1.571E-2
|
1.230E-1
|
8.953E-1
|
2
|
3
|
49
|
IPR007185
|
DNA pol alpha/epsilon bsu
|
InterPro
|
6.332E-4
|
1.571E-2
|
1.230E-1
|
8.953E-1
|
2
|
3
|
50
|
IPR018982
|
RQC domain
|
InterPro
|
6.332E-4
|
1.571E-2
|
1.230E-1
|
8.953E-1
|
2
|
3
|
Show 45 more annotations
|
7: Pathway [Display Chart]
785 annotations before applied cutoff / 10916 genes in category
|
8: Pubmed [Display Chart]
27408 annotations before applied cutoff / 51853 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
12791985
|
Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes.
|
Pubmed
|
8.210E-45
|
2.250E-40
|
2.429E-39
|
2.250E-40
|
23
|
34
|
2
|
19237606:gr
|
Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk.
|
GeneRIF
|
1.040E-40
|
9.502E-37
|
1.026E-35
|
2.851E-36
|
27
|
84
|
3
|
19237606
|
Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk.
|
Pubmed
|
1.040E-40
|
9.502E-37
|
1.026E-35
|
2.851E-36
|
27
|
84
|
4
|
15707391
|
DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system.
|
Pubmed
|
2.601E-32
|
1.782E-28
|
1.924E-27
|
7.130E-28
|
16
|
22
|
5
|
20496165:gr
|
Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.
|
GeneRIF
|
1.807E-31
|
8.256E-28
|
8.913E-27
|
4.954E-27
|
21
|
68
|
6
|
20496165
|
Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.
|
Pubmed
|
1.807E-31
|
8.256E-28
|
8.913E-27
|
4.954E-27
|
21
|
68
|
7
|
15226314
|
Human claspin is a ring-shaped DNA-binding protein with high affinity to branched DNA structures.
|
Pubmed
|
2.659E-31
|
1.041E-27
|
1.124E-26
|
7.288E-27
|
15
|
19
|
8
|
20522537:gr
|
Variation within DNA repair pathway genes and risk of multiple sclerosis.
|
GeneRIF
|
1.020E-30
|
3.105E-27
|
3.353E-26
|
2.795E-26
|
21
|
73
|
9
|
20522537
|
Variation within DNA repair pathway genes and risk of multiple sclerosis.
|
Pubmed
|
1.020E-30
|
3.105E-27
|
3.353E-26
|
2.795E-26
|
21
|
73
|
10
|
15232106
|
Self-assembling protein microarrays.
|
Pubmed
|
4.878E-29
|
1.337E-25
|
1.443E-24
|
1.337E-24
|
16
|
30
|
11
|
12614612
|
Interaction and assembly of murine pre-replicative complex proteins in yeast and mouse cells.
|
Pubmed
|
2.179E-28
|
5.428E-25
|
5.860E-24
|
5.971E-24
|
15
|
25
|
12
|
24958773
|
SIVA1 directs the E3 ubiquitin ligase RAD18 for PCNA monoubiquitination.
|
Pubmed
|
1.527E-27
|
3.487E-24
|
3.764E-23
|
4.184E-23
|
14
|
21
|
13
|
12045100
|
DNA replication in eukaryotic cells.
|
Pubmed
|
2.197E-26
|
4.632E-23
|
5.001E-22
|
6.021E-22
|
13
|
18
|
14
|
19714462:gr
|
Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.
|
GeneRIF
|
6.651E-26
|
1.215E-22
|
1.312E-21
|
1.823E-21
|
15
|
33
|
15
|
19714462
|
Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.
|
Pubmed
|
6.651E-26
|
1.215E-22
|
1.312E-21
|
1.823E-21
|
15
|
33
|
16
|
9111189
|
Which DNA polymerases are used for DNA-repair in eukaryotes?
|
Pubmed
|
9.037E-25
|
1.548E-21
|
1.671E-20
|
2.477E-20
|
12
|
16
|
17
|
22540012
|
Interactions of the human MCM-BP protein with MCM complex components and Dbf4.
|
Pubmed
|
1.161E-24
|
1.767E-21
|
1.908E-20
|
3.181E-20
|
11
|
12
|
18
|
24299456
|
Interaction of human minichromosome maintenance protein-binding protein with minichromosome maintenance 2-7.
|
Pubmed
|
1.161E-24
|
1.767E-21
|
1.908E-20
|
3.181E-20
|
11
|
12
|
19
|
12171929
|
A proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12/RFCs2-5 complex as a novel PCNA-binding protein.
|
Pubmed
|
3.318E-24
|
4.786E-21
|
5.167E-20
|
9.093E-20
|
14
|
31
|
20
|
19064572
|
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
|
Pubmed
|
7.520E-24
|
9.814E-21
|
1.060E-19
|
2.061E-19
|
22
|
170
|
21
|
19064572:gr
|
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
|
GeneRIF
|
7.520E-24
|
9.814E-21
|
1.060E-19
|
2.061E-19
|
22
|
170
|
22
|
18270339
|
Comprehensive analysis of DNA repair gene variants and risk of meningioma.
|
Pubmed
|
1.705E-23
|
2.032E-20
|
2.194E-19
|
4.674E-19
|
16
|
57
|
23
|
18270339:gr
|
Comprehensive analysis of DNA repair gene variants and risk of meningioma.
|
GeneRIF
|
1.705E-23
|
2.032E-20
|
2.194E-19
|
4.674E-19
|
16
|
57
|
24
|
24332808
|
PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.
|
Pubmed
|
2.924E-23
|
3.340E-20
|
3.605E-19
|
8.015E-19
|
27
|
340
|
25
|
15635413
|
Nucleolar proteome dynamics.
|
Pubmed
|
3.195E-23
|
3.503E-20
|
3.782E-19
|
8.757E-19
|
29
|
419
|
26
|
19135898
|
Purification of proteins associated with specific genomic Loci.
|
Pubmed
|
4.116E-23
|
4.339E-20
|
4.684E-19
|
1.128E-18
|
17
|
75
|
27
|
26527279
|
Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event.
|
Pubmed
|
9.503E-22
|
9.647E-19
|
1.041E-17
|
2.605E-17
|
21
|
182
|
28
|
11095689
|
The human homolog of Saccharomyces cerevisiae Mcm10 interacts with replication factors and dissociates from nuclease-resistant nuclear structures in G(2) phase.
|
Pubmed
|
2.991E-21
|
2.928E-18
|
3.161E-17
|
8.198E-17
|
11
|
18
|
29
|
10846177
|
Human Cdc7-related kinase complex. In vitro phosphorylation of MCM by concerted actions of Cdks and Cdc7 and that of a criticial threonine residue of Cdc7 bY Cdks.
|
Pubmed
|
3.544E-21
|
3.349E-18
|
3.616E-17
|
9.713E-17
|
9
|
9
|
30
|
11931757
|
Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication.
|
Pubmed
|
4.571E-21
|
4.176E-18
|
4.508E-17
|
1.253E-16
|
12
|
26
|
31
|
26299517
|
The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression.
|
Pubmed
|
1.651E-20
|
1.460E-17
|
1.576E-16
|
4.526E-16
|
16
|
84
|
32
|
10436018
|
The Cdc6 nucleotide-binding site regulates its activity in DNA replication in human cells.
|
Pubmed
|
5.452E-20
|
4.670E-17
|
5.041E-16
|
1.494E-15
|
10
|
15
|
33
|
19690177
|
Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.
|
Pubmed
|
6.521E-20
|
5.256E-17
|
5.675E-16
|
1.787E-15
|
12
|
31
|
34
|
19690177:gr
|
Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.
|
GeneRIF
|
6.521E-20
|
5.256E-17
|
5.675E-16
|
1.787E-15
|
12
|
31
|
35
|
11473323
|
RPA governs endonuclease switching during processing of Okazaki fragments in eukaryotes.
|
Pubmed
|
7.687E-19
|
5.963E-16
|
6.437E-15
|
2.107E-14
|
9
|
12
|
36
|
20301575
|
Fanconi Anemia
|
Pubmed
|
7.832E-19
|
5.963E-16
|
6.437E-15
|
2.147E-14
|
10
|
18
|
37
|
20453000
|
A Large-scale genetic association study of esophageal adenocarcinoma risk.
|
Pubmed
|
4.055E-18
|
2.925E-15
|
3.158E-14
|
1.111E-13
|
23
|
351
|
38
|
20453000:gr
|
A Large-scale genetic association study of esophageal adenocarcinoma risk.
|
GeneRIF
|
4.055E-18
|
2.925E-15
|
3.158E-14
|
1.111E-13
|
23
|
351
|
39
|
9822671
|
Replication factor C disengages from proliferating cell nuclear antigen (PCNA) upon sliding clamp formation, and PCNA itself tethers DNA polymerase delta to DNA.
|
Pubmed
|
6.029E-18
|
4.131E-15
|
4.460E-14
|
1.652E-13
|
8
|
9
|
40
|
21149733
|
L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability.
|
Pubmed
|
6.029E-18
|
4.131E-15
|
4.460E-14
|
1.652E-13
|
8
|
9
|
41
|
19692168
|
Genetic susceptibility to distinct bladder cancer subphenotypes.
|
Pubmed
|
1.890E-17
|
1.234E-14
|
1.332E-13
|
5.181E-13
|
24
|
422
|
42
|
19692168:gr
|
Genetic susceptibility to distinct bladder cancer subphenotypes.
|
GeneRIF
|
1.890E-17
|
1.234E-14
|
1.332E-13
|
5.181E-13
|
24
|
422
|
43
|
16622419
|
The human CENP-A centromeric nucleosome-associated complex.
|
Pubmed
|
5.181E-17
|
3.302E-14
|
3.565E-13
|
1.420E-12
|
11
|
36
|
44
|
18950845:gr
|
Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
|
GeneRIF
|
6.115E-17
|
3.809E-14
|
4.112E-13
|
1.676E-12
|
14
|
88
|
45
|
18950845
|
Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
|
Pubmed
|
7.221E-17
|
4.398E-14
|
4.748E-13
|
1.979E-12
|
14
|
89
|
46
|
19584272:gr
|
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
|
GeneRIF
|
1.095E-16
|
6.385E-14
|
6.893E-13
|
3.001E-12
|
8
|
11
|
47
|
19584272
|
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
|
Pubmed
|
1.095E-16
|
6.385E-14
|
6.893E-13
|
3.001E-12
|
8
|
11
|
48
|
16899510
|
Essential role of phosphorylation of MCM2 by Cdc7/Dbf4 in the initiation of DNA replication in mammalian cells.
|
Pubmed
|
1.273E-16
|
7.123E-14
|
7.690E-13
|
3.490E-12
|
7
|
7
|
49
|
17296731
|
Identification and characterization of a novel component of the human minichromosome maintenance complex.
|
Pubmed
|
1.273E-16
|
7.123E-14
|
7.690E-13
|
3.490E-12
|
7
|
7
|
50
|
20574454:gr
|
Polymorphisms in the base excision repair pathway and graft-versus-host disease.
|
GeneRIF
|
1.447E-16
|
7.625E-14
|
8.231E-13
|
3.965E-12
|
10
|
27
|
Show 45 more annotations
|
9: Interaction [Display Chart]
5653 annotations before applied cutoff / 16534 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
int:PCNA
|
PCNA interactions
|
|
6.623E-34
|
3.744E-30
|
3.451E-29
|
3.744E-30
|
48
|
295
|
2
|
int:POLA1
|
POLA1 interactions
|
|
2.758E-27
|
7.796E-24
|
7.185E-23
|
1.559E-23
|
23
|
54
|
3
|
int:RPA1
|
RPA1 interactions
|
|
2.125E-26
|
4.004E-23
|
3.691E-22
|
1.201E-22
|
50
|
470
|
4
|
int:MCM6
|
MCM6 interactions
|
|
8.139E-26
|
1.150E-22
|
1.060E-21
|
4.601E-22
|
26
|
88
|
5
|
int:MCM3
|
MCM3 interactions
|
|
3.955E-25
|
4.471E-22
|
4.121E-21
|
2.236E-21
|
28
|
115
|
6
|
int:MCM4
|
MCM4 interactions
|
|
7.561E-24
|
7.124E-21
|
6.566E-20
|
4.274E-20
|
25
|
92
|
7
|
int:MSH2
|
MSH2 interactions
|
|
1.306E-21
|
1.055E-18
|
9.725E-18
|
7.385E-18
|
26
|
124
|
8
|
int:BLM
|
BLM interactions
|
|
1.963E-21
|
1.387E-18
|
1.279E-17
|
1.110E-17
|
25
|
113
|
9
|
int:MCM7
|
MCM7 interactions
|
|
4.378E-21
|
2.750E-18
|
2.535E-17
|
2.475E-17
|
28
|
158
|
10
|
int:CDC7
|
CDC7 interactions
|
|
9.322E-21
|
5.270E-18
|
4.857E-17
|
5.270E-17
|
16
|
32
|
11
|
int:DBF4
|
DBF4 interactions
|
|
2.279E-20
|
1.171E-17
|
1.080E-16
|
1.288E-16
|
14
|
22
|
12
|
int:CDK1
|
CDK1 interactions
|
|
1.840E-19
|
8.667E-17
|
7.988E-16
|
1.040E-15
|
33
|
270
|
13
|
int:MRE11
|
MRE11 interactions
|
|
7.676E-19
|
3.338E-16
|
3.077E-15
|
4.339E-15
|
23
|
114
|
14
|
int:RFC1
|
RFC1 interactions
|
|
2.190E-18
|
8.844E-16
|
8.152E-15
|
1.238E-14
|
19
|
70
|
15
|
int:ATR
|
ATR interactions
|
|
2.928E-18
|
1.103E-15
|
1.017E-14
|
1.655E-14
|
22
|
107
|
16
|
int:MSH6
|
MSH6 interactions
|
|
4.709E-18
|
1.664E-15
|
1.534E-14
|
2.662E-14
|
20
|
84
|
17
|
int:E2F4
|
E2F4 interactions
|
|
8.305E-18
|
2.762E-15
|
2.545E-14
|
4.695E-14
|
22
|
112
|
18
|
int:ATM
|
ATM interactions
|
|
9.915E-18
|
3.114E-15
|
2.870E-14
|
5.605E-14
|
26
|
174
|
19
|
int:ORC2
|
ORC2 interactions
|
|
1.180E-17
|
3.510E-15
|
3.236E-14
|
6.670E-14
|
18
|
65
|
20
|
int:FANCD2
|
FANCD2 interactions
|
|
3.848E-17
|
1.088E-14
|
1.002E-13
|
2.175E-13
|
18
|
69
|
21
|
int:RPA2
|
RPA2 interactions
|
|
5.929E-17
|
1.596E-14
|
1.471E-13
|
3.352E-13
|
38
|
443
|
22
|
int:E2F1
|
E2F1 interactions
|
|
6.969E-17
|
1.791E-14
|
1.651E-13
|
3.940E-13
|
24
|
154
|
23
|
int:CDC45
|
CDC45 interactions
|
|
2.201E-16
|
5.411E-14
|
4.987E-13
|
1.244E-12
|
14
|
36
|
24
|
int:ORC1
|
ORC1 interactions
|
|
2.365E-16
|
5.570E-14
|
5.134E-13
|
1.337E-12
|
16
|
54
|
25
|
int:GINS3
|
GINS3 interactions
|
|
1.338E-15
|
3.026E-13
|
2.789E-12
|
7.566E-12
|
13
|
32
|
26
|
int:RFC2
|
RFC2 interactions
|
|
1.535E-15
|
3.338E-13
|
3.076E-12
|
8.678E-12
|
16
|
60
|
27
|
int:FEN1
|
FEN1 interactions
|
|
2.050E-15
|
4.293E-13
|
3.957E-12
|
1.159E-11
|
16
|
61
|
28
|
int:RAD51
|
RAD51 interactions
|
|
2.269E-15
|
4.581E-13
|
4.223E-12
|
1.283E-11
|
20
|
113
|
29
|
int:HIST1H2BG
|
HIST1H2BG interactions
|
|
4.316E-15
|
8.414E-13
|
7.755E-12
|
2.440E-11
|
26
|
222
|
30
|
int:TIMELESS
|
TIMELESS interactions
|
|
1.304E-14
|
2.458E-12
|
2.265E-11
|
7.373E-11
|
12
|
29
|
31
|
int:RAD21
|
RAD21 interactions
|
|
2.080E-14
|
3.793E-12
|
3.496E-11
|
1.176E-10
|
27
|
258
|
32
|
int:NBN
|
NBN interactions
|
|
3.579E-14
|
6.322E-12
|
5.827E-11
|
2.023E-10
|
17
|
85
|
33
|
int:RPA3
|
RPA3 interactions
|
|
3.715E-14
|
6.365E-12
|
5.866E-11
|
2.100E-10
|
32
|
381
|
34
|
int:CCNA2
|
CCNA2 interactions
|
|
5.079E-14
|
8.444E-12
|
7.783E-11
|
2.871E-10
|
19
|
116
|
35
|
int:HIST1H3A
|
HIST1H3A interactions
|
|
6.356E-14
|
1.027E-11
|
9.462E-11
|
3.593E-10
|
27
|
270
|
36
|
int:CHTF18
|
CHTF18 interactions
|
|
7.388E-14
|
1.160E-11
|
1.069E-10
|
4.176E-10
|
11
|
25
|
37
|
int:TIPIN
|
TIPIN interactions
|
|
1.490E-13
|
2.226E-11
|
2.052E-10
|
8.422E-10
|
9
|
14
|
38
|
int:CHAF1A
|
CHAF1A interactions
|
|
1.496E-13
|
2.226E-11
|
2.052E-10
|
8.460E-10
|
24
|
215
|
39
|
int:CCNE1
|
CCNE1 interactions
|
|
2.059E-13
|
2.985E-11
|
2.751E-10
|
1.164E-9
|
16
|
80
|
40
|
int:HIST1H3E
|
HIST1H3E interactions
|
|
2.893E-13
|
4.089E-11
|
3.769E-10
|
1.636E-9
|
23
|
201
|
41
|
int:GINS1
|
GINS1 interactions
|
|
3.100E-13
|
4.274E-11
|
3.940E-10
|
1.752E-9
|
7
|
7
|
42
|
int:CENPS
|
CENPS interactions
|
|
6.940E-13
|
9.340E-11
|
8.609E-10
|
3.923E-9
|
10
|
22
|
43
|
int:GINS4
|
GINS4 interactions
|
|
8.416E-13
|
1.090E-10
|
1.005E-9
|
4.757E-9
|
11
|
30
|
44
|
int:ORC5
|
ORC5 interactions
|
|
8.487E-13
|
1.090E-10
|
1.005E-9
|
4.798E-9
|
12
|
39
|
45
|
int:HIST1H4A
|
HIST1H4A interactions
|
|
9.969E-13
|
1.252E-10
|
1.154E-9
|
5.635E-9
|
20
|
154
|
46
|
int:CDT1
|
CDT1 interactions
|
|
1.150E-12
|
1.413E-10
|
1.302E-9
|
6.499E-9
|
14
|
62
|
47
|
int:ORC6
|
ORC6 interactions
|
|
1.930E-12
|
2.273E-10
|
2.095E-9
|
1.091E-8
|
11
|
32
|
48
|
int:MSH3
|
MSH3 interactions
|
|
1.930E-12
|
2.273E-10
|
2.095E-9
|
1.091E-8
|
11
|
32
|
49
|
int:MCM10
|
MCM10 interactions
|
|
3.089E-12
|
3.564E-10
|
3.285E-9
|
1.746E-8
|
13
|
54
|
50
|
int:USP37
|
USP37 interactions
|
|
3.995E-12
|
4.517E-10
|
4.163E-9
|
2.258E-8
|
16
|
96
|
Show 45 more annotations
|
10: Cytoband [Display Chart]
238 annotations before applied cutoff / 34661 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
1p32
|
1p32
|
|
6.318E-5
|
1.504E-2
|
9.100E-2
|
1.504E-2
|
4
|
27
|
2
|
7p15-p14
|
7p15-p14
|
|
3.860E-4
|
4.593E-2
|
2.780E-1
|
9.187E-2
|
2
|
4
|
|
11: Transcription Factor Binding Site [Display Chart]
421 annotations before applied cutoff / 9770 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
V$E2F Q6
|
V$E2F Q6
|
|
8.077E-37
|
2.755E-34
|
1.824E-33
|
3.401E-34
|
41
|
182
|
2
|
V$E2F Q4
|
V$E2F Q4
|
|
1.309E-36
|
2.755E-34
|
1.824E-33
|
5.510E-34
|
41
|
184
|
3
|
V$E2F4DP1 01
|
V$E2F4DP1 01
|
|
2.144E-33
|
3.009E-31
|
1.992E-30
|
9.027E-31
|
39
|
189
|
4
|
V$E2F1 Q6
|
V$E2F1 Q6
|
|
7.952E-33
|
8.370E-31
|
5.542E-30
|
3.348E-30
|
38
|
181
|
5
|
V$E2F4DP2 01
|
V$E2F4DP2 01
|
|
1.543E-32
|
9.279E-31
|
6.144E-30
|
6.495E-30
|
38
|
184
|
6
|
V$E2F1DP1 01
|
V$E2F1DP1 01
|
|
1.543E-32
|
9.279E-31
|
6.144E-30
|
6.495E-30
|
38
|
184
|
7
|
V$E2F1DP2 01
|
V$E2F1DP2 01
|
|
1.543E-32
|
9.279E-31
|
6.144E-30
|
6.495E-30
|
38
|
184
|
8
|
V$E2F 03
|
V$E2F 03
|
|
6.901E-32
|
3.631E-30
|
2.404E-29
|
2.905E-29
|
38
|
191
|
9
|
V$E2F1DP1RB 01
|
V$E2F1DP1RB 01
|
|
3.235E-31
|
1.362E-29
|
9.017E-29
|
1.362E-28
|
37
|
184
|
10
|
V$E2F 02
|
V$E2F 02
|
|
3.235E-31
|
1.362E-29
|
9.017E-29
|
1.362E-28
|
37
|
184
|
11
|
V$E2F Q6 01
|
V$E2F Q6 01
|
|
6.503E-30
|
2.489E-28
|
1.648E-27
|
2.738E-27
|
36
|
184
|
12
|
V$E2F1 Q3
|
V$E2F1 Q3
|
|
2.175E-29
|
7.629E-28
|
5.051E-27
|
9.155E-27
|
36
|
190
|
13
|
V$E2F Q4 01
|
V$E2F Q4 01
|
|
1.527E-28
|
4.944E-27
|
3.274E-26
|
6.428E-26
|
35
|
185
|
14
|
V$E2F Q3
|
V$E2F Q3
|
|
5.868E-28
|
1.765E-26
|
1.168E-25
|
2.470E-25
|
34
|
177
|
15
|
V$E2F Q3 01
|
V$E2F Q3 01
|
|
3.383E-27
|
9.494E-26
|
6.286E-25
|
1.424E-24
|
34
|
186
|
16
|
SGCGSSAAA V$E2F1DP2 01
|
SGCGSSAAA V$E2F1DP2 01
|
|
4.154E-27
|
1.093E-25
|
7.236E-25
|
1.749E-24
|
30
|
131
|
17
|
V$E2F1 Q6 01
|
V$E2F1 Q6 01
|
|
5.933E-27
|
1.469E-25
|
9.728E-25
|
2.498E-24
|
34
|
189
|
18
|
V$E2F1 Q4 01
|
V$E2F1 Q4 01
|
|
2.333E-26
|
5.457E-25
|
3.613E-24
|
9.823E-24
|
33
|
181
|
19
|
V$E2F1 Q4
|
V$E2F1 Q4
|
|
1.491E-12
|
3.304E-11
|
2.188E-10
|
6.278E-10
|
21
|
189
|
20
|
KTGGYRSGAA UNKNOWN
|
KTGGYRSGAA UNKNOWN
|
|
1.826E-12
|
3.845E-11
|
2.546E-10
|
7.689E-10
|
13
|
55
|
21
|
V$E2F 01
|
V$E2F 01
|
|
6.872E-10
|
1.378E-8
|
9.122E-8
|
2.893E-7
|
11
|
55
|
22
|
V$E2F1 Q3 01
|
V$E2F1 Q3 01
|
|
1.562E-5
|
2.989E-4
|
1.979E-3
|
6.575E-3
|
13
|
200
|
23
|
ACTAYRNNNCCCR UNKNOWN
|
ACTAYRNNNCCCR UNKNOWN
|
|
1.614E-3
|
2.955E-2
|
1.956E-1
|
6.796E-1
|
13
|
320
|
Show 18 more annotations
|
12: Gene Family [Display Chart]
104 annotations before applied cutoff / 18194 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
548
|
Fanconi anemia complementation groups
|
genenames.org
|
1.946E-20
|
2.023E-18
|
1.058E-17
|
2.023E-18
|
12
|
20
|
2
|
1085
|
MCM family
|
genenames.org
|
1.381E-13
|
7.184E-12
|
3.754E-11
|
1.437E-11
|
7
|
9
|
3
|
1335
|
Ankyrin repeat domain containing|BRCA1 B complex
|
genenames.org
|
6.057E-9
|
1.575E-7
|
8.231E-7
|
6.300E-7
|
4
|
4
|
4
|
931
|
GINS complex
|
genenames.org
|
6.057E-9
|
1.575E-7
|
8.231E-7
|
6.300E-7
|
4
|
4
|
5
|
413
|
AAA ATPases
|
genenames.org
|
2.095E-8
|
4.358E-7
|
2.278E-6
|
2.179E-6
|
8
|
53
|
6
|
535
|
DNA polymerases
|
genenames.org
|
4.045E-8
|
7.010E-7
|
3.664E-6
|
4.206E-6
|
6
|
23
|
7
|
1269
|
EF-hand domain containing|Nucleotide excision repair|Transcription and export complex 2
|
genenames.org
|
4.105E-7
|
5.361E-6
|
2.802E-5
|
4.269E-5
|
5
|
18
|
8
|
581
|
HAUS augmin like complex
|
genenames.org
|
4.124E-7
|
5.361E-6
|
2.802E-5
|
4.289E-5
|
4
|
8
|
9
|
1336
|
Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex
|
genenames.org
|
6.840E-6
|
7.904E-5
|
4.131E-4
|
7.113E-4
|
3
|
5
|
10
|
1051
|
Nucleoporins
|
genenames.org
|
8.723E-6
|
9.072E-5
|
4.741E-4
|
9.072E-4
|
5
|
32
|
11
|
135
|
Zinc fingers GRF-type
|
genenames.org
|
2.363E-5
|
2.234E-4
|
1.167E-3
|
2.457E-3
|
3
|
7
|
12
|
362
|
WD repeat domain containing
|
genenames.org
|
1.227E-4
|
1.064E-3
|
5.559E-3
|
1.276E-2
|
10
|
262
|
13
|
1167
|
DNA helicases
|
genenames.org
|
4.299E-4
|
3.439E-3
|
1.797E-2
|
4.471E-2
|
3
|
17
|
14
|
1026
|
MutS homologs
|
genenames.org
|
7.742E-4
|
5.368E-3
|
2.805E-2
|
8.052E-2
|
2
|
5
|
15
|
1049
|
RecQ like helicases
|
genenames.org
|
7.742E-4
|
5.368E-3
|
2.805E-2
|
8.052E-2
|
2
|
5
|
16
|
1050
|
Topoisomerases
|
genenames.org
|
1.155E-3
|
6.670E-3
|
3.486E-2
|
1.201E-1
|
2
|
6
|
17
|
960
|
Origin recognition complex
|
genenames.org
|
1.155E-3
|
6.670E-3
|
3.486E-2
|
1.201E-1
|
2
|
6
|
18
|
1347
|
Lysine methyltransferases|Myb/SANT domain containing|Polycomb repressive complex 2
|
genenames.org
|
1.155E-3
|
6.670E-3
|
3.486E-2
|
1.201E-1
|
2
|
6
|
19
|
761
|
Structural maintenance of chromosomes proteins|Cohesin complex
|
genenames.org
|
1.607E-3
|
8.795E-3
|
4.597E-2
|
1.671E-1
|
2
|
7
|
20
|
982
|
E2F transcription factors
|
genenames.org
|
2.130E-3
|
1.108E-2
|
5.789E-2
|
2.215E-1
|
2
|
8
|
21
|
817
|
Exosome complex
|
genenames.org
|
4.904E-3
|
2.318E-2
|
1.212E-1
|
5.101E-1
|
2
|
12
|
22
|
573
|
Small leucine rich repeat proteoglycans
|
genenames.org
|
4.904E-3
|
2.318E-2
|
1.212E-1
|
5.101E-1
|
2
|
12
|
23
|
544
|
Exonucleases
|
genenames.org
|
8.712E-3
|
3.858E-2
|
2.017E-1
|
9.060E-1
|
2
|
16
|
24
|
1108
|
Myosins, class XIX
|
genenames.org
|
8.904E-3
|
3.858E-2
|
2.017E-1
|
9.260E-1
|
1
|
1
|
25
|
684
|
Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases
|
genenames.org
|
9.816E-3
|
4.083E-2
|
2.134E-1
|
1.000E0
|
2
|
17
|
26
|
870
|
Minor histocompatibility antigens
|
genenames.org
|
1.056E-2
|
4.223E-2
|
2.207E-1
|
1.000E0
|
3
|
51
|
27
|
498
|
WD repeat domain containing|DDB1 and CUL4 associated factors
|
genenames.org
|
1.098E-2
|
4.229E-2
|
2.210E-1
|
1.000E0
|
2
|
18
|
Show 22 more annotations
|
13: Coexpression [Display Chart]
5874 annotations before applied cutoff / 21867 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
M2156
|
Genes up-regulated in MCF7 cells (breast cancer) at 24 h of estradiol [PubChemID=5757] treatment.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
3.898E-171
|
2.290E-167
|
2.119E-166
|
2.290E-167
|
131
|
324
|
2
|
M1915
|
Genes down-regulated in neural stem cells (NSC) at 60 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.192E-136
|
3.501E-133
|
3.241E-132
|
7.002E-133
|
108
|
277
|
3
|
M16010
|
Genes down-regulated in H1975 cells (non-small cell lung cancer, NSCLC) resistant to gefitinib [PubChem=123631] after treatment with EGFR inhibitor CL-387785 [PubChem=2776] for 24h.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
4.916E-127
|
9.625E-124
|
8.909E-123
|
2.888E-123
|
100
|
251
|
4
|
M5925
|
Genes encoding cell cycle related targets of E2F transcription factors.
|
MSigDB H: Hallmark Gene Sets (v5.1)
|
3.966E-95
|
5.824E-92
|
5.391E-91
|
2.330E-91
|
77
|
200
|
5
|
M2879
|
Selected genes down-regulated in response to the Ras inhibitor salirasib [PubChem=5469318] in a panel of cancer cell lines with constantly active HRAS [GeneID=3265].
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
2.651E-91
|
3.114E-88
|
2.882E-87
|
1.557E-87
|
88
|
342
|
6
|
M9516
|
Genes constituting the BRCA2-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC >= 0.4) with that of BRCA2 [GeneID=675] across a compendium of normal tissues.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
2.496E-85
|
2.443E-82
|
2.261E-81
|
1.466E-81
|
90
|
423
|
7
|
M1916
|
Genes down-regulated in neural stem cells (NSC) at both 36 h and 60 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.686E-80
|
1.414E-77
|
1.309E-76
|
9.901E-77
|
54
|
89
|
8
|
M14340
|
Genes down-regulated in MCF-7 cells (breast cancer) after knockdown of YBX1 [GeneID=4904] by RNAi.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.213E-75
|
8.905E-73
|
8.242E-72
|
7.124E-72
|
66
|
201
|
9
|
M15969
|
Cluster 1: genes up-regulated by RB1, CDNK2A [GeneID=1029;5925], and one of the E2Fs (E2F1, E2F2, or E2F3 [GeneID=1869;1870;1871]).
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.709E-75
|
1.116E-72
|
1.033E-71
|
1.004E-71
|
48
|
70
|
10
|
GSE39556 CD8A DC VS NK CELL MOUSE 3H POST POLYIC INJ UP
|
Genes up-regulated after poly(IC) injection: CD8A [GeneID=925] dendritic cells versus NK cells.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
3.996E-74
|
2.347E-71
|
2.173E-70
|
2.347E-70
|
65
|
200
|
11
|
M8520
|
Cluster 6 of method A: up-regulation of these genes in patients with non-small cell lung cancer (NSCLC) predicts poor survival outcome.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.063E-73
|
5.678E-71
|
5.255E-70
|
6.245E-70
|
84
|
456
|
12
|
M2132
|
Genes down-regulated in RS4;11 cells (MLL, mixed lineage leukemia) in response to SB216763 [PubChemID=176158], an inhibitor of GSK3B [GeneID=2932].
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.242E-72
|
6.081E-70
|
5.628E-69
|
7.297E-69
|
78
|
374
|
13
|
M1913
|
Genes down-regulated in neural stem cells (NSC) at 36 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
6.562E-70
|
2.965E-67
|
2.744E-66
|
3.854E-66
|
61
|
185
|
14
|
M18562
|
Genes down-regulated in response to both hypoxia and overexpression of an active form of HIF1A [GeneID=3091].
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
2.515E-68
|
1.055E-65
|
9.767E-65
|
1.477E-64
|
69
|
289
|
15
|
M18811
|
Genes constituting the XPRSS-Int network: intersection of genes whose expression correlates with BRCA1, BRCA2, ATM, and CHEK2 [GeneID=672;675;472;11200] in a compendium of normal tissues.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
4.440E-66
|
1.739E-63
|
1.609E-62
|
2.608E-62
|
57
|
168
|
16
|
M3580
|
Genes up-regulated in comparison of wild type CD8 effector T cells at day 6 versus those from mice defficient for TRAF6 [GeneID=7189] at day 10.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
2.944E-64
|
1.081E-61
|
1.000E-60
|
1.729E-60
|
59
|
200
|
17
|
M15664
|
The 'Cervical Cancer Proliferation Cluster' (CCPC): genes whose expression in cervical carcinoma positively correlates with that of the HPV E6 and E7 oncogenes; they are also differentially expressed according to disease outcome.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.149E-62
|
3.970E-60
|
3.675E-59
|
6.750E-59
|
52
|
140
|
18
|
M4288
|
Genes up-regulated in MCF10A cells (breast cancer) grown at low (mesenchymal phenotype) compared to those grown at high (epithelial, basal-like phenotype) confluency.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.990E-62
|
6.493E-60
|
6.010E-59
|
1.169E-58
|
56
|
180
|
19
|
M15305
|
Genes constituting the BRCA-centered network (BCN).
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
3.456E-62
|
1.068E-59
|
9.889E-59
|
2.030E-58
|
49
|
117
|
20
|
M11563
|
Genes involved in DNA repair, compiled manually by the authors.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
3.269E-60
|
9.602E-58
|
8.887E-57
|
1.920E-56
|
59
|
230
|
21
|
M19048
|
Genes down-regulated in T98G cells (glioblastoma) by TNC [GeneID=3371].
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
7.760E-59
|
2.171E-56
|
2.009E-55
|
4.558E-55
|
50
|
142
|
22
|
M854
|
Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.452E-58
|
3.876E-56
|
3.588E-55
|
8.527E-55
|
65
|
328
|
23
|
GSE13547 CTRL VS ANTI IGM STIM BCELL 12H UP
|
Genes up-regulated in B lymphocytes: control versus stimulated by anti-IgM for 12h.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
2.738E-57
|
6.993E-55
|
6.472E-54
|
1.608E-53
|
53
|
182
|
24
|
M1577
|
Strongly up-regulated at 16-24 h during differentiation of 3T3-L1 cells (fibroblast) into adipocytes.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
8.803E-57
|
2.154E-54
|
1.994E-53
|
5.171E-53
|
44
|
101
|
25
|
M5198
|
Genes down-regulated in quiescent vs dividing CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.197E-56
|
2.812E-54
|
2.603E-53
|
7.031E-53
|
42
|
87
|
26
|
M3577
|
Genes up-regulated in comparison of wild type CD8 effector T cells at day 6 versus those at day 10.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
2.255E-56
|
5.095E-54
|
4.716E-53
|
1.325E-52
|
54
|
200
|
27
|
M2074
|
Genes periodically expressed in synchronized HeLa cells (cervical carcinoma), with peak during the G1/S phase of cell cycle.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
2.886E-56
|
6.278E-54
|
5.811E-53
|
1.695E-52
|
49
|
147
|
28
|
M11537
|
Fibroblast serum response genes showing periodic expression during the cell cycle; excluded from the core serum response signature.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
4.269E-56
|
8.956E-54
|
8.289E-53
|
2.508E-52
|
49
|
148
|
29
|
GSE18893 TCONV VS TREG 24H TNF STIM UP
|
Genes up-regulated in lymphocytes treated with TNF [GeneID=7124] for 24h: T conv versus T reg cells.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
7.797E-55
|
1.579E-52
|
1.462E-51
|
4.580E-51
|
53
|
200
|
30
|
M4077
|
Genes identified by method 2 as coordinately down-regulated late in HMEC cells (mammary epithelium) during acinar development in vitro.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.367E-53
|
2.676E-51
|
2.477E-50
|
8.029E-50
|
58
|
277
|
31
|
M2606
|
Cell cycle genes significantly (p =< 0.05) changed in fibroblast cells at 6 h after exposure to ionizing radiation.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
2.261E-53
|
4.191E-51
|
3.879E-50
|
1.328E-49
|
40
|
85
|
32
|
M2257
|
Cellular genes up-regulated in forskin fibroblasts by expression of CMV EI86 protein off an adenovirus vector.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
2.283E-53
|
4.191E-51
|
3.879E-50
|
1.341E-49
|
36
|
60
|
33
|
M2431
|
DNA repair and replication genes up-regulated in melanoma patients who will relapse vs patients who will not.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
5.509E-53
|
9.807E-51
|
9.077E-50
|
3.236E-49
|
36
|
61
|
34
|
M7094
|
Genes down-regulated in adult fibroblasts with inactivated RB1 [GeneID=5925] by Cre-lox: acute loss of function (LOF) of RB1.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
5.767E-53
|
9.963E-51
|
9.222E-50
|
3.388E-49
|
54
|
228
|
35
|
M2075
|
Genes periodically expressed in synchronized HeLa cells (cervical carcinoma), with peak during the S phase of cell cycle.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
2.939E-52
|
4.933E-50
|
4.565E-49
|
1.726E-48
|
48
|
162
|
36
|
M5294
|
Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 72 h.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
2.691E-50
|
4.272E-48
|
3.954E-47
|
1.581E-46
|
50
|
200
|
37
|
M5300
|
Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 40 h.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
2.691E-50
|
4.272E-48
|
3.954E-47
|
1.581E-46
|
50
|
200
|
38
|
M3155
|
Genes up-regulated in quiescent CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors compared to the dividing cells from CML (chronic myeloid leukemia) patients.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.216E-49
|
1.880E-47
|
1.740E-46
|
7.142E-46
|
48
|
181
|
39
|
M19875
|
Genes up-regulated in nsopharyngeal carcinoma relative to the normal tissue.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
2.882E-49
|
4.341E-47
|
4.017E-46
|
1.693E-45
|
56
|
294
|
40
|
GSE40274 CTRL VS FOXP3 TRANSDUCED ACTIVATED CD4 TCELL UP
|
Genes up-regulated in CD4 T conv: control versus over-expression of FOXP3 [GeneID=50943].
|
MSigDB C7: Immunologic Signatures (v5.1)
|
8.241E-49
|
1.181E-46
|
1.093E-45
|
4.841E-45
|
49
|
200
|
41
|
GSE21063 WT VS NFATC1 KO 8H ANTI IGM STIM BCELL UP
|
Genes up-regulated in B lymphocytes stimulated by anti-IgM for 8h: wildtype versus NFATC1 [GeneID=4772] knockout.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
8.241E-49
|
1.181E-46
|
1.093E-45
|
4.841E-45
|
49
|
200
|
42
|
M9372
|
Genes involved in DNA replication, compiled manually by the authors.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
2.857E-48
|
3.952E-46
|
3.658E-45
|
1.678E-44
|
44
|
146
|
43
|
M14985
|
Genes up-regulated in SKOC-3 cells (ovarian cancer) after YB-1 (YBX1) [GeneID=4904] knockdown by RNAi.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
2.893E-48
|
3.952E-46
|
3.658E-45
|
1.699E-44
|
55
|
290
|
44
|
M5292
|
Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 40 h.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
2.446E-47
|
3.266E-45
|
3.023E-44
|
1.437E-43
|
48
|
200
|
45
|
M7854
|
Differentially expressed genes in a panel of xenografts representing 8 common pediatric tumors compared to the normal tissues.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
1.234E-46
|
1.611E-44
|
1.491E-43
|
7.250E-43
|
40
|
116
|
46
|
M5041
|
Genes up-regulated in comparison of splenic primary CD8 effector T cells at day 8 post-acute infection versus splenic secondary CD8 effector T cells at day 8 post-acute infection.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
5.442E-46
|
6.949E-44
|
6.432E-43
|
3.196E-42
|
47
|
199
|
47
|
M3766
|
Up-regulated genes whose expression correlated with histologic grade of invasive breast cancer tumors: comparison of grade 1 vs grade 3.
|
MSigDB C2: CGP Curated Gene Sets (v5.1)
|
5.735E-46
|
7.168E-44
|
6.634E-43
|
3.369E-42
|
43
|
151
|
48
|
M4604
|
Genes up-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7 versus CD25- T cells treated with IL4 [GeneID=3565] at day 7.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
7.038E-46
|
8.268E-44
|
7.653E-43
|
4.134E-42
|
47
|
200
|
49
|
GSE25088 WT VS STAT6 KO MACROPHAGE IL4 STIM DN
|
Genes down-regulated in bone marrow-derived macrophages treated with IL4 [GeneID=3565]: wildtype versus STAT6 [GeneID=6778] knockout.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
7.038E-46
|
8.268E-44
|
7.653E-43
|
4.134E-42
|
47
|
200
|
50
|
GSE33292 WT VS TCF1 KO DN3 THYMOCYTE DN
|
Genes down-regulated in DN3 thymocytes: wildtype versus TCF7 [GeneID=6932] knockout.
|
MSigDB C7: Immunologic Signatures (v5.1)
|
7.038E-46
|
8.268E-44
|
7.653E-43
|
4.134E-42
|
47
|
200
|
Show 45 more annotations
|
14: Coexpression Atlas [Display Chart]
2033 annotations before applied cutoff / 20974 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GSM399403 500
|
alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3
|
Immgen.org, GSE15907
|
9.263E-148
|
1.883E-144
|
1.543E-143
|
1.883E-144
|
129
|
417
|
2
|
GSM399452 500
|
B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3
|
Immgen.org, GSE15907
|
4.824E-123
|
4.904E-120
|
4.018E-119
|
9.807E-120
|
114
|
409
|
3
|
GSM538387 500
|
alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3
|
Immgen.org, GSE15907
|
1.415E-119
|
9.587E-117
|
7.856E-116
|
2.876E-116
|
112
|
410
|
4
|
GSM538358 500
|
B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3
|
Immgen.org, GSE15907
|
4.669E-111
|
2.373E-108
|
1.945E-107
|
9.492E-108
|
106
|
400
|
5
|
GSM791143 500
|
alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3
|
Immgen.org, GSE15907
|
7.983E-110
|
3.246E-107
|
2.660E-106
|
1.623E-106
|
105
|
397
|
6
|
GSM791154 500
|
alpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3
|
Immgen.org, GSE15907
|
1.796E-104
|
6.086E-102
|
4.987E-101
|
3.652E-101
|
100
|
376
|
7
|
GSM538357 500
|
B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1
|
Immgen.org, GSE15907
|
6.979E-99
|
2.027E-96
|
1.661E-95
|
1.419E-95
|
100
|
422
|
8
|
GSM791149 500
|
alpha beta T cells, preT.DN3B.Th, Lin-/lo CD25hi CD44- CD28+, Thymus, avg-3
|
Immgen.org, GSE15907
|
2.300E-98
|
5.844E-96
|
4.789E-95
|
4.675E-95
|
99
|
413
|
9
|
GSM399397 500
|
alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3
|
Immgen.org, GSE15907
|
6.891E-97
|
1.557E-94
|
1.276E-93
|
1.401E-93
|
97
|
399
|
10
|
GSM791141 500
|
alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2
|
Immgen.org, GSE15907
|
1.659E-94
|
3.373E-92
|
2.764E-91
|
3.373E-91
|
97
|
420
|
11
|
12Dn Top 500 All
|
12Dn Top 500 All
|
Brain Map - Allen iN
|
2.845E-94
|
5.259E-92
|
4.309E-91
|
5.784E-91
|
102
|
495
|
12
|
fetal replicating Top 500 All
|
fetal replicating Top 500 All
|
Brain Map - Barres
|
3.551E-94
|
6.016E-92
|
4.930E-91
|
7.219E-91
|
102
|
496
|
13
|
GSM538348 500
|
B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2
|
Immgen.org, GSE15907
|
4.407E-90
|
6.891E-88
|
5.647E-87
|
8.959E-87
|
94
|
419
|
14
|
GSM791136 500
|
alpha beta T cells, preT.DN2.Th, Lin-/lo CD25hi CD44+ cKit+, Thymus, avg-3
|
Immgen.org, GSE15907
|
5.626E-90
|
8.170E-88
|
6.695E-87
|
1.144E-86
|
94
|
420
|
15
|
GSM476664 500
|
gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3
|
Immgen.org, GSE15907
|
1.377E-88
|
1.867E-86
|
1.530E-85
|
2.800E-85
|
93
|
419
|
16
|
GSM538355 500
|
B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2
|
Immgen.org, GSE15907
|
2.834E-88
|
3.602E-86
|
2.951E-85
|
5.763E-85
|
93
|
422
|
17
|
fetal replicating Top 500 Cluster 1
|
fetal replicating Top 500 Cluster 1
|
Brain Map - Barres
|
3.537E-87
|
4.230E-85
|
3.467E-84
|
7.192E-84
|
80
|
267
|
18
|
GSM538350 500
|
B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1
|
Immgen.org, GSE15907
|
2.972E-84
|
3.357E-82
|
2.751E-81
|
6.043E-81
|
90
|
418
|
19
|
12Dn Top 500 Cluster 4
|
12Dn Top 500 Cluster 4
|
Brain Map - Allen iN
|
3.297E-84
|
3.527E-82
|
2.891E-81
|
6.702E-81
|
61
|
117
|
20
|
GSM791105 500
|
Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3
|
Immgen.org, GSE15907
|
1.433E-78
|
1.456E-76
|
1.194E-75
|
2.913E-75
|
85
|
402
|
21
|
GSM476660 500
|
gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3
|
Immgen.org, GSE15907
|
5.604E-76
|
5.425E-74
|
4.445E-73
|
1.139E-72
|
84
|
414
|
22
|
Lungmap Mouse e16.5 Proliferative fibroblast Top 500 All
|
Mouse Lung E16.5 Proliferative fibroblast top 500
|
Lungmap Mouse Single Cell (Lungmap.net)
|
5.906E-74
|
5.458E-72
|
4.473E-71
|
1.201E-70
|
85
|
452
|
23
|
GSM538207 500
|
B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3
|
Immgen.org, GSE15907
|
1.535E-73
|
1.357E-71
|
1.112E-70
|
3.121E-70
|
80
|
380
|
24
|
GSM791108 500
|
Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2
|
Immgen.org, GSE15907
|
9.459E-69
|
8.013E-67
|
6.566E-66
|
1.923E-65
|
78
|
401
|
25
|
GSM791131 500
|
B cells, MLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-3
|
Immgen.org, GSE15907
|
4.951E-68
|
4.026E-66
|
3.299E-65
|
1.006E-64
|
79
|
425
|
26
|
GSM791114 500
|
Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3
|
Immgen.org, GSE15907
|
2.276E-67
|
1.780E-65
|
1.458E-64
|
4.627E-64
|
77
|
401
|
27
|
gudmap dev gonad e11.5 M PrimGermCell Oct k2 1000
|
dev gonad e11.5 M PrimGermCell Oct k-means-cluster#2 top-relative-expression-ranked 1000
|
Gudmap Mouse ST 1.0
|
8.876E-65
|
6.683E-63
|
5.477E-62
|
1.805E-61
|
65
|
258
|
28
|
GSM538352 500
|
B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2
|
Immgen.org, GSE15907
|
2.144E-64
|
1.557E-62
|
1.276E-61
|
4.359E-61
|
74
|
388
|
29
|
GSM791139 500
|
alpha beta T cells, preT.DN2A.Th, Lin-/lo CD25hi CD44+ cKithi, Thymus, avg-2
|
Immgen.org, GSE15907
|
5.869E-64
|
4.114E-62
|
3.372E-61
|
1.193E-60
|
75
|
409
|
30
|
GSM399450 500
|
B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2
|
Immgen.org, GSE15907
|
3.391E-63
|
2.224E-61
|
1.823E-60
|
6.894E-60
|
74
|
402
|
31
|
GSM605898 500
|
alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3
|
Immgen.org, GSE15907
|
3.391E-63
|
2.224E-61
|
1.823E-60
|
6.894E-60
|
74
|
402
|
32
|
GSM605781 500
|
gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3
|
Immgen.org, GSE15907
|
2.938E-60
|
1.866E-58
|
1.529E-57
|
5.972E-57
|
70
|
373
|
33
|
Lungmap Mouse e16.5 Endothelial SubClass Proliferative Endothelial Top 500 All
|
Mouse Lung E16.5 Proliferative Endothelial top500
|
Lungmap Mouse Single Cell (Lungmap.net)
|
5.070E-60
|
3.124E-58
|
2.560E-57
|
1.031E-56
|
74
|
442
|
34
|
GSM791124 500
|
B cells, MLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R-, Bone marrow, avg-2
|
Immgen.org, GSE15907
|
6.120E-59
|
3.659E-57
|
2.999E-56
|
1.244E-55
|
72
|
422
|
35
|
GSM791134 500
|
alpha beta T cells, preT.DN2-3.Th, Lin-/lo CD25hi CD44Int, Thymus, avg-2
|
Immgen.org, GSE15907
|
7.078E-57
|
4.111E-55
|
3.369E-54
|
1.439E-53
|
70
|
415
|
36
|
gudmap dev gonad e12.5 M GermCellTestis Oct k2 1000
|
dev gonad e12.5 M GermCellTestis Oct k-means-cluster#2 top-relative-expression-ranked 1000
|
Gudmap Mouse ST 1.0
|
1.609E-56
|
9.085E-55
|
7.445E-54
|
3.271E-53
|
60
|
266
|
37
|
gudmap dev gonad e13.5 F MeioticGermCell Oct k2 1000
|
dev gonad e13.5 F MeioticGermCell Oct k-means-cluster#2 top-relative-expression-ranked 1000
|
Gudmap Mouse ST 1.0
|
6.522E-56
|
3.584E-54
|
2.937E-53
|
1.326E-52
|
66
|
361
|
38
|
GSM791122 500
|
Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2
|
Immgen.org, GSE15907
|
7.045E-51
|
3.769E-49
|
3.089E-48
|
1.432E-47
|
65
|
410
|
39
|
gudmap kidney P3 CapMes Crym k4 1000
|
kidney P3 CapMes Crym k-means-cluster#4 top-relative-expression-ranked 1000
|
Gudmap Mouse MOE430.2
|
2.600E-50
|
1.355E-48
|
1.111E-47
|
5.286E-47
|
59
|
317
|
40
|
GSM476658 500
|
gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2
|
Immgen.org, GSE15907
|
4.765E-50
|
2.422E-48
|
1.985E-47
|
9.688E-47
|
65
|
422
|
41
|
GSM538340 500
|
B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3
|
Immgen.org, GSE15907
|
1.957E-49
|
9.703E-48
|
7.952E-47
|
3.978E-46
|
63
|
395
|
42
|
GSM538338 500
|
alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2
|
Immgen.org, GSE15907
|
3.185E-49
|
1.542E-47
|
1.263E-46
|
6.474E-46
|
63
|
398
|
43
|
GSM538418 500
|
B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1
|
Immgen.org, GSE15907
|
5.783E-47
|
2.734E-45
|
2.240E-44
|
1.176E-43
|
60
|
377
|
44
|
GSM538345 500
|
B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2
|
Immgen.org, GSE15907
|
1.837E-45
|
8.300E-44
|
6.802E-43
|
3.735E-42
|
60
|
399
|
45
|
Lungmap Mouse e16.5 Epithelial SubClass Uncommitted AT Progenitor Top 500 All
|
Mouse Lung E16.5 Epithelial Uncommitted AT Progenitor top 500
|
Lungmap Mouse Single Cell (Lungmap.net)
|
1.837E-45
|
8.300E-44
|
6.802E-43
|
3.735E-42
|
60
|
399
|
46
|
GSM791110 500
|
Stem Cells, SC.MPP34F.BM, Lineage- cKit+ Sca-1+ flk2+ CD34+, Bone marrow, avg-2
|
Immgen.org, GSE15907
|
4.009E-44
|
1.772E-42
|
1.452E-41
|
8.149E-41
|
59
|
401
|
47
|
GSM476675 500
|
gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3
|
Immgen.org, GSE15907
|
5.621E-44
|
2.431E-42
|
1.992E-41
|
1.143E-40
|
56
|
349
|
48
|
gudmap kidney e10.5 UretericTip HoxB7 k4 1000
|
kidney e10.5 UretericTip HoxB7 k-means-cluster#4 top-relative-expression-ranked 1000
|
Gudmap Mouse MOE430.2
|
8.242E-43
|
3.491E-41
|
2.861E-40
|
1.676E-39
|
55
|
348
|
49
|
Lungmap Mouse e14.5 Epithelial (GSE52583) Top 500 All
|
Mouse Lung E14.5 Epithelial top 500
|
Lungmap Mouse Single Cell (Lungmap.net)
|
1.491E-42
|
6.188E-41
|
5.071E-40
|
3.032E-39
|
60
|
446
|
50
|
GSM605773 500
|
alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2
|
Immgen.org, GSE15907
|
4.690E-42
|
1.907E-40
|
1.563E-39
|
9.534E-39
|
55
|
359
|
Show 45 more annotations
|
15: Computational [Display Chart]
442 annotations before applied cutoff / 9399 genes in category
|
16: MicroRNA [Display Chart]
1171 annotations before applied cutoff / 19844 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
hsa-miR-24:miRTarbase
|
hsa-miR-24:miRTarbase
|
miRTarbase
|
8.968E-7
|
1.050E-3
|
8.026E-3
|
1.050E-3
|
7
|
38
|
2
|
hsa-miR-192:miRTarbase
|
hsa-miR-192:miRTarbase
|
miRTarbase
|
2.275E-5
|
1.332E-2
|
1.018E-1
|
2.664E-2
|
5
|
25
|
|
17: Drug [Display Chart]
20115 annotations before applied cutoff / 22098 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
C488369
|
dasatinib
|
CTD
|
8.509E-99
|
1.368E-94
|
1.434E-93
|
1.712E-94
|
102
|
472
|
2
|
D000069439
|
Dasatinib
|
CTD
|
1.360E-98
|
1.368E-94
|
1.434E-93
|
2.735E-94
|
102
|
474
|
3
|
D008154
|
Lucanthone
|
CTD
|
4.425E-52
|
2.967E-48
|
3.111E-47
|
8.901E-48
|
52
|
212
|
4
|
C500026
|
palbociclib
|
CTD
|
4.743E-51
|
2.385E-47
|
2.501E-46
|
9.542E-47
|
48
|
172
|
5
|
CID000004156
|
methyl methanesulfonate
|
Stitch
|
3.430E-49
|
1.380E-45
|
1.447E-44
|
6.900E-45
|
60
|
364
|
6
|
CID000002210
|
NSC351140
|
Stitch
|
2.785E-47
|
9.336E-44
|
9.790E-43
|
5.601E-43
|
52
|
258
|
7
|
CID000003657
|
hydroxyurea
|
Stitch
|
1.073E-46
|
3.083E-43
|
3.233E-42
|
2.158E-42
|
62
|
438
|
8
|
C408982
|
CPG-oligonucleotide
|
CTD
|
5.593E-45
|
1.406E-41
|
1.475E-40
|
1.125E-40
|
45
|
184
|
9
|
C059765
|
amphotericin B, deoxycholate drug combination
|
CTD
|
4.590E-44
|
1.026E-40
|
1.076E-39
|
9.234E-40
|
56
|
365
|
10
|
C496197
|
trans-10,cis-12-conjugated linoleic acid
|
CTD
|
5.782E-43
|
1.163E-39
|
1.220E-38
|
1.163E-38
|
43
|
176
|
11
|
D002509
|
Cephaloridine
|
CTD
|
4.007E-37
|
7.328E-34
|
7.684E-33
|
8.060E-33
|
55
|
464
|
12
|
C058305
|
phenethyl isothiocyanate
|
CTD
|
2.282E-36
|
3.824E-33
|
4.011E-32
|
4.589E-32
|
51
|
393
|
13
|
CID000005192
|
sebacate
|
Stitch
|
1.295E-28
|
2.003E-25
|
2.101E-24
|
2.604E-24
|
33
|
181
|
14
|
CID000002538
|
NSC302991
|
Stitch
|
2.458E-27
|
3.315E-24
|
3.476E-23
|
4.944E-23
|
41
|
353
|
15
|
C547185
|
riccardin D
|
CTD
|
2.472E-27
|
3.315E-24
|
3.476E-23
|
4.972E-23
|
24
|
76
|
16
|
CID000001151
|
AC1Q6S3S
|
Stitch
|
4.298E-24
|
5.404E-21
|
5.666E-20
|
8.646E-20
|
27
|
142
|
17
|
6902 DN
|
0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT HG-U133A
|
Broad Institute CMAP
|
9.327E-24
|
1.104E-20
|
1.157E-19
|
1.876E-19
|
30
|
196
|
18
|
CID000005746
|
mitomycin C
|
Stitch
|
2.623E-23
|
2.931E-20
|
3.074E-19
|
5.276E-19
|
32
|
241
|
19
|
CID000006623
|
bisphenol A
|
Stitch
|
3.216E-23
|
3.404E-20
|
3.570E-19
|
6.469E-19
|
31
|
223
|
20
|
CID000001174
|
uracil
|
Stitch
|
6.760E-23
|
6.799E-20
|
7.130E-19
|
1.360E-18
|
33
|
269
|
21
|
CID000000597
|
cytosine
|
Stitch
|
1.307E-22
|
1.252E-19
|
1.313E-18
|
2.630E-18
|
40
|
441
|
22
|
C014026
|
hexamethylene bisacetamide
|
CTD
|
8.698E-21
|
7.952E-18
|
8.339E-17
|
1.750E-16
|
18
|
57
|
23
|
1998 DN
|
Niclosamide [50-65-7]; Down 200; 12.2uM; HL60; HG-U133A
|
Broad Institute CMAP
|
9.894E-21
|
8.653E-18
|
9.074E-17
|
1.990E-16
|
27
|
188
|
24
|
D048789
|
Phytoestrogens
|
CTD
|
9.323E-20
|
7.814E-17
|
8.194E-16
|
1.875E-15
|
18
|
64
|
25
|
CID002723601
|
6-thioguanine
|
Stitch
|
1.101E-18
|
8.857E-16
|
9.288E-15
|
2.214E-14
|
22
|
130
|
26
|
CID000072271
|
UCN-01
|
Stitch
|
3.243E-18
|
2.509E-15
|
2.631E-14
|
6.522E-14
|
23
|
154
|
27
|
D014747
|
Vinblastine
|
CTD
|
4.786E-18
|
3.566E-15
|
3.739E-14
|
9.627E-14
|
28
|
260
|
28
|
CID000000625
|
AC1Q6S3R
|
Stitch
|
2.047E-17
|
1.471E-14
|
1.542E-13
|
4.118E-13
|
17
|
71
|
29
|
D007840
|
Latex
|
CTD
|
3.146E-17
|
2.182E-14
|
2.288E-13
|
6.328E-13
|
24
|
190
|
30
|
CID000000621
|
NSC82625
|
Stitch
|
6.615E-17
|
4.436E-14
|
4.651E-13
|
1.331E-12
|
21
|
138
|
31
|
C006551
|
2-amino-2-methyl-1-propanol
|
CTD
|
9.184E-17
|
5.959E-14
|
6.249E-13
|
1.847E-12
|
30
|
342
|
32
|
D016685
|
Mitomycin
|
CTD
|
2.104E-16
|
1.323E-13
|
1.387E-12
|
4.232E-12
|
32
|
408
|
33
|
CID000001139
|
NSC46713
|
Stitch
|
2.584E-16
|
1.575E-13
|
1.652E-12
|
5.197E-12
|
24
|
208
|
34
|
CID000065577
|
Topo
|
Stitch
|
5.747E-16
|
3.400E-13
|
3.565E-12
|
1.156E-11
|
21
|
153
|
35
|
CID000345751
|
NSC403510
|
Stitch
|
6.346E-16
|
3.647E-13
|
3.824E-12
|
1.276E-11
|
18
|
101
|
36
|
CID000000646
|
AC1Q6S3Y
|
Stitch
|
1.488E-15
|
8.316E-13
|
8.720E-12
|
2.994E-11
|
17
|
90
|
37
|
CID005282473
|
Zinostatino
|
Stitch
|
2.586E-15
|
1.406E-12
|
1.474E-11
|
5.202E-11
|
16
|
78
|
38
|
C010914
|
2,4-diaminotoluene
|
CTD
|
6.754E-15
|
3.575E-12
|
3.749E-11
|
1.359E-10
|
24
|
240
|
39
|
6895 DN
|
0297417-0002B [362658-29-5]; Down 200; 10uM; PC3; HT HG-U133A
|
Broad Institute CMAP
|
7.584E-15
|
3.912E-12
|
4.102E-11
|
1.526E-10
|
22
|
195
|
40
|
CID000000593
|
NSC20261
|
Stitch
|
1.423E-14
|
7.155E-12
|
7.503E-11
|
2.862E-10
|
23
|
224
|
41
|
C056493
|
imiquimod
|
CTD
|
1.667E-14
|
8.177E-12
|
8.575E-11
|
3.353E-10
|
14
|
59
|
42
|
CID000000622
|
2'-deoxyadenosine 5'-triphosphate
|
Stitch
|
4.189E-14
|
2.006E-11
|
2.104E-10
|
8.426E-10
|
17
|
109
|
43
|
6900 DN
|
0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT HG-U133A
|
Broad Institute CMAP
|
5.304E-14
|
2.481E-11
|
2.602E-10
|
1.067E-9
|
21
|
191
|
44
|
CID000011254
|
diepoxybutane
|
Stitch
|
7.758E-14
|
3.547E-11
|
3.719E-10
|
1.561E-9
|
17
|
113
|
45
|
C063002
|
2,3-dimethoxy-1,4-naphthoquinone
|
CTD
|
9.403E-14
|
4.203E-11
|
4.408E-10
|
1.891E-9
|
19
|
153
|
46
|
2439 DN
|
Menadione [58-27-5]; Down 200; 23.2uM; HL60; HT HG-U133A
|
Broad Institute CMAP
|
9.836E-14
|
4.301E-11
|
4.510E-10
|
1.978E-9
|
21
|
197
|
47
|
CID000005955
|
4NQO
|
Stitch
|
1.212E-13
|
5.186E-11
|
5.438E-10
|
2.437E-9
|
17
|
116
|
48
|
D012835
|
Silver Nitrate
|
CTD
|
1.619E-13
|
6.785E-11
|
7.115E-10
|
3.257E-9
|
17
|
118
|
49
|
CID005473385
|
Thioguanine (usan
|
Stitch
|
1.708E-13
|
7.012E-11
|
7.353E-10
|
3.436E-9
|
15
|
84
|
50
|
978 DN
|
pyrvinium pamoate; Down 200; 1.25uM; MCF7; HT HG-U133A EA
|
Broad Institute CMAP
|
2.413E-13
|
9.709E-11
|
1.018E-9
|
4.854E-9
|
20
|
183
|
Show 45 more annotations
|
18: Disease [Display Chart]
1799 annotations before applied cutoff / 16150 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
umls:C3469521
|
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)
|
DisGeNET Curated
|
8.380E-21
|
1.508E-17
|
1.217E-16
|
1.508E-17
|
30
|
219
|
2
|
umls:C0015625
|
Fanconi Anemia
|
DisGeNET Curated
|
2.208E-19
|
1.986E-16
|
1.603E-15
|
3.972E-16
|
30
|
245
|
3
|
umls:C0004135
|
Ataxia Telangiectasia
|
DisGeNET Curated
|
1.079E-13
|
6.471E-11
|
5.224E-10
|
1.941E-10
|
22
|
196
|
4
|
umls:C0346153
|
Breast Cancer, Familial
|
DisGeNET Curated
|
4.072E-12
|
1.831E-9
|
1.478E-8
|
7.326E-9
|
18
|
146
|
5
|
umls:C0677776
|
Hereditary Breast and Ovarian Cancer Syndrome
|
DisGeNET Curated
|
1.399E-10
|
5.032E-8
|
4.062E-7
|
2.516E-7
|
11
|
51
|
6
|
cv:C1861028
|
Tracheoesophageal fistula
|
Clinical Variations
|
3.084E-10
|
9.248E-8
|
7.466E-7
|
5.549E-7
|
8
|
21
|
7
|
umls:C0265202
|
Seckel syndrome
|
DisGeNET Curated
|
5.486E-9
|
1.410E-6
|
1.138E-5
|
9.869E-6
|
7
|
19
|
8
|
umls:C0027672
|
Neoplastic Syndromes, Hereditary
|
DisGeNET Curated
|
9.950E-9
|
2.237E-6
|
1.806E-5
|
1.790E-5
|
10
|
58
|
9
|
umls:C0023452
|
Leukemia, Lymphocytic, Acute, L1
|
DisGeNET Curated
|
1.171E-8
|
2.342E-6
|
1.890E-5
|
2.108E-5
|
23
|
387
|
10
|
umls:C1333600
|
Hereditary Malignant Neoplasm
|
DisGeNET BeFree
|
1.655E-8
|
2.915E-6
|
2.353E-5
|
2.978E-5
|
10
|
61
|
11
|
umls:C0035335
|
Retinoblastoma
|
DisGeNET Curated
|
1.782E-8
|
2.915E-6
|
2.353E-5
|
3.206E-5
|
25
|
463
|
12
|
umls:C1336076
|
Sporadic Breast Carcinoma
|
DisGeNET BeFree
|
3.113E-8
|
4.666E-6
|
3.767E-5
|
5.600E-5
|
14
|
147
|
13
|
umls:C0005859
|
Bloom Syndrome
|
DisGeNET Curated
|
1.127E-7
|
1.559E-5
|
1.259E-4
|
2.027E-4
|
8
|
41
|
14
|
cv:C0346153
|
Familial cancer of breast
|
Clinical Variations
|
9.625E-7
|
1.154E-4
|
9.319E-4
|
1.732E-3
|
6
|
24
|
15
|
114480
|
BREAST CANCER
|
OMIM
|
9.625E-7
|
1.154E-4
|
9.319E-4
|
1.732E-3
|
6
|
24
|
16
|
umls:C0679427
|
myeloblastosis
|
DisGeNET BeFree
|
1.125E-6
|
1.264E-4
|
1.021E-3
|
2.023E-3
|
5
|
14
|
17
|
umls:C1868684
|
EAR, PATELLA, SHORT STATURE SYNDROME
|
DisGeNET Curated
|
1.478E-6
|
1.564E-4
|
1.263E-3
|
2.659E-3
|
4
|
7
|
18
|
umls:C0342573
|
PITUITARY DWARFISM I
|
DisGeNET Curated
|
1.667E-6
|
1.666E-4
|
1.345E-3
|
2.999E-3
|
5
|
15
|
19
|
umls:C0016412
|
Folic Acid Deficiency
|
DisGeNET Curated
|
2.566E-6
|
2.430E-4
|
1.961E-3
|
4.616E-3
|
6
|
28
|
20
|
umls:C0025958
|
Microcephaly
|
DisGeNET Curated
|
2.823E-6
|
2.503E-4
|
2.021E-3
|
5.079E-3
|
12
|
155
|
21
|
227650
|
FANCONI ANEMIA; FA
|
OMIM
|
2.922E-6
|
2.503E-4
|
2.021E-3
|
5.257E-3
|
4
|
8
|
22
|
umls:C3711387
|
Autosomal Recessive Primary Microcephaly
|
DisGeNET BeFree
|
3.354E-6
|
2.743E-4
|
2.214E-3
|
6.034E-3
|
5
|
17
|
23
|
umls:C2986665
|
Early-Stage Breast Carcinoma
|
DisGeNET BeFree
|
3.914E-6
|
3.062E-4
|
2.471E-3
|
7.042E-3
|
8
|
64
|
24
|
umls:C0334634
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
DisGeNET Curated
|
4.133E-6
|
3.098E-4
|
2.501E-3
|
7.435E-3
|
17
|
317
|
25
|
umls:C1134719
|
Invasive Ductal Breast Carcinoma
|
DisGeNET Curated
|
6.465E-6
|
4.652E-4
|
3.755E-3
|
1.163E-2
|
14
|
228
|
26
|
umls:C0151779
|
Cutaneous Melanoma
|
DisGeNET Curated
|
6.740E-6
|
4.663E-4
|
3.765E-3
|
1.212E-2
|
15
|
261
|
27
|
umls:C0043119
|
Werner Syndrome
|
DisGeNET Curated
|
1.062E-5
|
7.078E-4
|
5.714E-3
|
1.911E-2
|
8
|
73
|
28
|
umls:C3539878
|
Triple Negative Breast Neoplasms
|
DisGeNET BeFree
|
1.201E-5
|
7.468E-4
|
6.028E-3
|
2.161E-2
|
20
|
456
|
29
|
umls:C3697776
|
Proliferative verrucous oral leukoplakia
|
DisGeNET BeFree
|
1.204E-5
|
7.468E-4
|
6.028E-3
|
2.166E-2
|
3
|
4
|
30
|
umls:C0032339
|
Rothmund-Thomson syndrome
|
DisGeNET Curated
|
1.698E-5
|
1.018E-3
|
8.221E-3
|
3.055E-2
|
5
|
23
|
31
|
umls:C0043346
|
Xeroderma Pigmentosum
|
DisGeNET Curated
|
2.077E-5
|
1.205E-3
|
9.730E-3
|
3.736E-2
|
9
|
104
|
32
|
umls:C0023530
|
Leukopenia
|
DisGeNET Curated
|
2.635E-5
|
1.481E-3
|
1.196E-2
|
4.741E-2
|
12
|
193
|
33
|
umls:C0153467
|
Malignant tumor of peritoneum
|
DisGeNET BeFree
|
2.818E-5
|
1.536E-3
|
1.240E-2
|
5.070E-2
|
4
|
13
|
34
|
umls:C1333991
|
Hereditary Non-Polyposis Colon Cancer Type 2
|
DisGeNET Curated
|
2.977E-5
|
1.575E-3
|
1.272E-2
|
5.356E-2
|
3
|
5
|
35
|
umls:C1333990
|
Hereditary Nonpolyposis Colorectal Cancer
|
DisGeNET Curated
|
5.668E-5
|
2.914E-3
|
2.352E-2
|
1.020E-1
|
9
|
118
|
36
|
umls:C0005695
|
Bladder Neoplasm
|
DisGeNET Curated
|
6.295E-5
|
3.143E-3
|
2.537E-2
|
1.132E-1
|
15
|
316
|
37
|
umls:C0349566
|
Squamous cell carcinoma of tongue
|
DisGeNET BeFree
|
6.465E-5
|
3.143E-3
|
2.537E-2
|
1.163E-1
|
9
|
120
|
38
|
umls:C0010606
|
Adenoid Cystic Carcinoma
|
DisGeNET Curated
|
8.558E-5
|
4.051E-3
|
3.270E-2
|
1.540E-1
|
11
|
185
|
39
|
umls:C1112474
|
Small cell carcinoma of esophagus
|
DisGeNET BeFree
|
1.020E-4
|
4.586E-3
|
3.702E-2
|
1.834E-1
|
3
|
7
|
40
|
umls:C0392475
|
Roberts-SC phocomelia syndrome
|
DisGeNET Curated
|
1.020E-4
|
4.586E-3
|
3.702E-2
|
1.834E-1
|
3
|
7
|
41
|
umls:C0346429
|
Multiple malignancy
|
DisGeNET BeFree
|
1.086E-4
|
4.764E-3
|
3.846E-2
|
1.953E-1
|
11
|
190
|
42
|
umls:C0431350
|
Primary microcephaly
|
DisGeNET Curated
|
1.139E-4
|
4.829E-3
|
3.898E-2
|
2.049E-1
|
4
|
18
|
43
|
umls:C1336735
|
Treatment related acute myeloid leukaemia
|
DisGeNET BeFree
|
1.154E-4
|
4.829E-3
|
3.898E-2
|
2.076E-1
|
6
|
53
|
44
|
umls:C0036503
|
Sebaceous Gland Neoplasms
|
DisGeNET Curated
|
1.614E-4
|
6.508E-3
|
5.253E-2
|
2.904E-1
|
3
|
8
|
45
|
umls:C1559154
|
Rash and Dermatitis Adverse Event Associated with Chemoradiation
|
DisGeNET BeFree
|
1.628E-4
|
6.508E-3
|
5.253E-2
|
2.929E-1
|
7
|
80
|
46
|
umls:C1334411
|
Locally Metastatic Malignant Neoplasm
|
DisGeNET BeFree
|
2.108E-4
|
7.065E-3
|
5.703E-2
|
3.793E-1
|
2
|
2
|
47
|
umls:C0424091
|
Loss of interest
|
DisGeNET BeFree
|
2.108E-4
|
7.065E-3
|
5.703E-2
|
3.793E-1
|
2
|
2
|
48
|
cv:C0677776
|
BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer
|
Clinical Variations
|
2.108E-4
|
7.065E-3
|
5.703E-2
|
3.793E-1
|
2
|
2
|
49
|
umls:C0031149
|
Peritoneal Neoplasms
|
DisGeNET BeFree
|
2.108E-4
|
7.065E-3
|
5.703E-2
|
3.793E-1
|
2
|
2
|
50
|
120435
|
LYNCH SYNDROME I
|
OMIM
|
2.108E-4
|
7.065E-3
|
5.703E-2
|
3.793E-1
|
2
|
2
|
Show 45 more annotations
|
|